US8519204B2 - Stabilization methods for microbial-derived olefins - Google Patents
Stabilization methods for microbial-derived olefins Download PDFInfo
- Publication number
- US8519204B2 US8519204B2 US12/753,413 US75341310A US8519204B2 US 8519204 B2 US8519204 B2 US 8519204B2 US 75341310 A US75341310 A US 75341310A US 8519204 B2 US8519204 B2 US 8519204B2
- Authority
- US
- United States
- Prior art keywords
- composition
- olefin
- farnesene
- phenolic antioxidant
- certain embodiments
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active, expires
Links
- 150000001336 alkenes Chemical class 0.000 title claims abstract description 268
- 238000000034 method Methods 0.000 title claims abstract description 109
- 230000000813 microbial effect Effects 0.000 title claims abstract description 94
- 230000006641 stabilisation Effects 0.000 title abstract description 3
- 238000011105 stabilization Methods 0.000 title abstract description 3
- 239000000203 mixture Substances 0.000 claims abstract description 257
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 claims abstract description 257
- 238000005984 hydrogenation reaction Methods 0.000 claims abstract description 159
- 230000000087 stabilizing effect Effects 0.000 claims abstract description 7
- JSNRRGGBADWTMC-UHFFFAOYSA-N (6E)-7,11-dimethyl-3-methylene-1,6,10-dodecatriene Chemical compound CC(C)=CCCC(C)=CCCC(=C)C=C JSNRRGGBADWTMC-UHFFFAOYSA-N 0.000 claims description 335
- CXENHBSYCFFKJS-UHFFFAOYSA-N (3E,6E)-3,7,11-Trimethyl-1,3,6,10-dodecatetraene Natural products CC(C)=CCCC(C)=CCC=C(C)C=C CXENHBSYCFFKJS-UHFFFAOYSA-N 0.000 claims description 164
- 229930009668 farnesene Natural products 0.000 claims description 140
- 239000003054 catalyst Substances 0.000 claims description 129
- 239000002530 phenolic antioxidant Substances 0.000 claims description 82
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 76
- 239000001257 hydrogen Substances 0.000 claims description 76
- 229910052739 hydrogen Inorganic materials 0.000 claims description 76
- YFHFHLSMISYUAQ-UHFFFAOYSA-N farnesane Chemical compound CCC(C)CCCC(C)CCCC(C)C YFHFHLSMISYUAQ-UHFFFAOYSA-N 0.000 claims description 75
- 150000001875 compounds Chemical class 0.000 claims description 24
- 238000000746 purification Methods 0.000 claims description 23
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims description 18
- -1 diglycerides Chemical class 0.000 claims description 16
- 150000002353 farnesene derivatives Chemical class 0.000 claims description 14
- 239000000260 (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol Substances 0.000 claims description 11
- XBGUIVFBMBVUEG-UHFFFAOYSA-N 1-methyl-4-(1,5-dimethyl-4-hexenylidene)-1-cyclohexene Chemical compound CC(C)=CCCC(C)=C1CCC(C)=CC1 XBGUIVFBMBVUEG-UHFFFAOYSA-N 0.000 claims description 11
- YHBUQBJHSRGZNF-HNNXBMFYSA-N alpha-bisabolene Natural products CC(C)=CCC=C(C)[C@@H]1CCC(C)=CC1 YHBUQBJHSRGZNF-HNNXBMFYSA-N 0.000 claims description 11
- 229930003493 bisabolene Natural products 0.000 claims description 11
- 229930002886 farnesol Natural products 0.000 claims description 11
- 229940043259 farnesol Drugs 0.000 claims description 11
- KKOXKGNSUHTUBV-UHFFFAOYSA-N racemic zingiberene Natural products CC(C)=CCCC(C)C1CC=C(C)C=C1 KKOXKGNSUHTUBV-UHFFFAOYSA-N 0.000 claims description 11
- CRDAMVZIKSXKFV-UHFFFAOYSA-N trans-Farnesol Natural products CC(C)=CCCC(C)=CCCC(C)=CCO CRDAMVZIKSXKFV-UHFFFAOYSA-N 0.000 claims description 11
- KKOXKGNSUHTUBV-LSDHHAIUSA-N zingiberene Chemical compound CC(C)=CCC[C@H](C)[C@H]1CC=C(C)C=C1 KKOXKGNSUHTUBV-LSDHHAIUSA-N 0.000 claims description 11
- 229930001895 zingiberene Natural products 0.000 claims description 11
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 claims description 10
- XESZUVZBAMCAEJ-UHFFFAOYSA-N 4-tert-butylcatechol Chemical group CC(C)(C)C1=CC=C(O)C(O)=C1 XESZUVZBAMCAEJ-UHFFFAOYSA-N 0.000 claims description 10
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 claims description 10
- 229940031439 squalene Drugs 0.000 claims description 10
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 claims description 10
- 239000012535 impurity Substances 0.000 claims description 9
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 claims description 8
- NOWQRWPUNHMSAF-UHFFFAOYSA-N bisabolane Chemical compound CC(C)CCCC(C)C1CCC(C)CC1 NOWQRWPUNHMSAF-UHFFFAOYSA-N 0.000 claims description 7
- 235000010354 butylated hydroxytoluene Nutrition 0.000 claims description 7
- OPLCSTZDXXUYDU-UHFFFAOYSA-N 2,4-dimethyl-6-tert-butylphenol Chemical compound CC1=CC(C)=C(O)C(C(C)(C)C)=C1 OPLCSTZDXXUYDU-UHFFFAOYSA-N 0.000 claims description 6
- IMOYOUMVYICGCA-UHFFFAOYSA-N 2-tert-butyl-4-hydroxyanisole Chemical compound COC1=CC=C(O)C=C1C(C)(C)C IMOYOUMVYICGCA-UHFFFAOYSA-N 0.000 claims description 6
- MRBKEAMVRSLQPH-UHFFFAOYSA-N 3-tert-butyl-4-hydroxyanisole Chemical group COC1=CC=C(O)C(C(C)(C)C)=C1 MRBKEAMVRSLQPH-UHFFFAOYSA-N 0.000 claims description 6
- 229930014717 bisabolane Natural products 0.000 claims description 6
- 238000007701 flash-distillation Methods 0.000 claims description 6
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 6
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 claims description 5
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 claims description 5
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 claims description 5
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 claims description 5
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 claims description 5
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 claims description 5
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 claims description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 5
- 235000021283 resveratrol Nutrition 0.000 claims description 5
- 229940016667 resveratrol Drugs 0.000 claims description 5
- 239000007864 aqueous solution Substances 0.000 claims description 4
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical group OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 claims description 4
- 238000004811 liquid chromatography Methods 0.000 claims description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 4
- 150000008442 polyphenolic compounds Chemical group 0.000 claims description 4
- 235000013824 polyphenols Nutrition 0.000 claims description 4
- 238000001179 sorption measurement Methods 0.000 claims description 4
- 238000004508 fractional distillation Methods 0.000 claims description 3
- 238000000638 solvent extraction Methods 0.000 claims description 3
- BGHCVCJVXZWKCC-UHFFFAOYSA-N tetradecane Chemical compound CCCCCCCCCCCCCC BGHCVCJVXZWKCC-UHFFFAOYSA-N 0.000 claims description 3
- 150000003626 triacylglycerols Chemical class 0.000 claims description 3
- CRDAMVZIKSXKFV-FBXUGWQNSA-N (2-cis,6-cis)-farnesol Chemical compound CC(C)=CCC\C(C)=C/CC\C(C)=C/CO CRDAMVZIKSXKFV-FBXUGWQNSA-N 0.000 claims 1
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 claims 1
- 230000008569 process Effects 0.000 abstract description 35
- 239000000047 product Substances 0.000 description 58
- 239000007788 liquid Substances 0.000 description 57
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 51
- 239000003085 diluting agent Substances 0.000 description 50
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 44
- PXHVJJICTQNCMI-UHFFFAOYSA-N nickel Substances [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 40
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 38
- 238000006243 chemical reaction Methods 0.000 description 32
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 28
- 229940087305 limonene Drugs 0.000 description 25
- 235000001510 limonene Nutrition 0.000 description 25
- 210000004027 cell Anatomy 0.000 description 23
- 229940087168 alpha tocopherol Drugs 0.000 description 22
- 229960000984 tocofersolan Drugs 0.000 description 22
- 239000002076 α-tocopherol Substances 0.000 description 22
- 235000004835 α-tocopherol Nutrition 0.000 description 22
- 229910052593 corundum Inorganic materials 0.000 description 21
- 229910001845 yogo sapphire Inorganic materials 0.000 description 21
- 229910052717 sulfur Inorganic materials 0.000 description 20
- 239000007789 gas Substances 0.000 description 19
- JSNRRGGBADWTMC-QINSGFPZSA-N (E)-beta-Farnesene Natural products CC(C)=CCC\C(C)=C/CCC(=C)C=C JSNRRGGBADWTMC-QINSGFPZSA-N 0.000 description 18
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 18
- YSNRTFFURISHOU-UHFFFAOYSA-N beta-farnesene Natural products C=CC(C)CCC=C(C)CCC=C(C)C YSNRTFFURISHOU-UHFFFAOYSA-N 0.000 description 18
- 239000000523 sample Substances 0.000 description 18
- 229920006395 saturated elastomer Polymers 0.000 description 18
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 17
- 239000011593 sulfur Substances 0.000 description 17
- 239000010410 layer Substances 0.000 description 16
- 229910052759 nickel Inorganic materials 0.000 description 16
- CFJYNSNXFXLKNS-UHFFFAOYSA-N p-menthane Chemical class CC(C)C1CCC(C)CC1 CFJYNSNXFXLKNS-UHFFFAOYSA-N 0.000 description 14
- 150000004563 farnesanes Chemical class 0.000 description 13
- JXBSHSBNOVLGHF-UHFFFAOYSA-N 10-cis-Dihydrofarnesen Natural products CC=C(C)CCC=C(C)CCC=C(C)C JXBSHSBNOVLGHF-UHFFFAOYSA-N 0.000 description 12
- HFPZCAJZSCWRBC-UHFFFAOYSA-N p-cymene Chemical compound CC(C)C1=CC=C(C)C=C1 HFPZCAJZSCWRBC-UHFFFAOYSA-N 0.000 description 12
- 229910052763 palladium Inorganic materials 0.000 description 12
- CRDAMVZIKSXKFV-YFVJMOTDSA-N (2-trans,6-trans)-farnesol Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CO CRDAMVZIKSXKFV-YFVJMOTDSA-N 0.000 description 11
- 241000282326 Felis catus Species 0.000 description 10
- 238000011068 loading method Methods 0.000 description 10
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 10
- 239000000376 reactant Substances 0.000 description 10
- 150000002430 hydrocarbons Chemical class 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- DIOQZVSQGTUSAI-UHFFFAOYSA-N decane Chemical compound CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 description 8
- 238000001914 filtration Methods 0.000 description 8
- 229930195733 hydrocarbon Natural products 0.000 description 8
- 229910052751 metal Inorganic materials 0.000 description 8
- 239000002184 metal Substances 0.000 description 8
- 239000000377 silicon dioxide Substances 0.000 description 8
- 150000003505 terpenes Chemical class 0.000 description 8
- 229910001868 water Inorganic materials 0.000 description 8
- 230000007423 decrease Effects 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 229930004008 p-menthane Natural products 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- RMDGVETXJWRSGT-UHFFFAOYSA-N 2,6,10-trimethylundecane Chemical compound CC(C)CCCC(C)CCCC(C)C RMDGVETXJWRSGT-UHFFFAOYSA-N 0.000 description 6
- 239000004215 Carbon black (E152) Substances 0.000 description 6
- 208000033962 Fontaine progeroid syndrome Diseases 0.000 description 6
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 6
- 239000012530 fluid Substances 0.000 description 6
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 5
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 5
- 229910052794 bromium Inorganic materials 0.000 description 5
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 5
- 239000000920 calcium hydroxide Substances 0.000 description 5
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 5
- 229910052799 carbon Inorganic materials 0.000 description 5
- 238000004821 distillation Methods 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 238000004064 recycling Methods 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- CPLXHLVBOLITMK-UHFFFAOYSA-N Magnesium oxide Chemical compound [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 4
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- UAHWPYUMFXYFJY-UHFFFAOYSA-N beta-myrcene Chemical compound CC(C)=CCCC(=C)C=C UAHWPYUMFXYFJY-UHFFFAOYSA-N 0.000 description 4
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 4
- 238000004517 catalytic hydrocracking Methods 0.000 description 4
- 230000003247 decreasing effect Effects 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 150000002978 peroxides Chemical class 0.000 description 4
- 239000003208 petroleum Substances 0.000 description 4
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Substances [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 4
- 238000007086 side reaction Methods 0.000 description 4
- 229940032094 squalane Drugs 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 3
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229910052782 aluminium Inorganic materials 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 235000011116 calcium hydroxide Nutrition 0.000 description 3
- 229910052802 copper Inorganic materials 0.000 description 3
- 239000010949 copper Substances 0.000 description 3
- 230000009849 deactivation Effects 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- 238000004817 gas chromatography Methods 0.000 description 3
- 150000002431 hydrogen Chemical class 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 3
- 150000002739 metals Chemical class 0.000 description 3
- 230000036961 partial effect Effects 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000002002 slurry Substances 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- GRWFGVWFFZKLTI-IUCAKERBSA-N (-)-α-pinene Chemical compound CC1=CC[C@@H]2C(C)(C)[C@H]1C2 GRWFGVWFFZKLTI-IUCAKERBSA-N 0.000 description 2
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 2
- 229910003294 NiMo Inorganic materials 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- MOYAFQVGZZPNRA-UHFFFAOYSA-N Terpinolene Chemical compound CC(C)=C1CCC(C)=CC1 MOYAFQVGZZPNRA-UHFFFAOYSA-N 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- MCMNRKCIXSYSNV-UHFFFAOYSA-N Zirconium dioxide Chemical compound O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- VYBREYKSZAROCT-UHFFFAOYSA-N alpha-myrcene Natural products CC(=C)CCCC(=C)C=C VYBREYKSZAROCT-UHFFFAOYSA-N 0.000 description 2
- HMTAHNDPLDKYJT-CBBWQLFWSA-N amorpha-4,11-diene Chemical compound C1=C(C)CC[C@H]2[C@H](C)CC[C@@H](C(C)=C)[C@H]21 HMTAHNDPLDKYJT-CBBWQLFWSA-N 0.000 description 2
- HMTAHNDPLDKYJT-UHFFFAOYSA-N amorphadiene Natural products C1=C(C)CCC2C(C)CCC(C(C)=C)C21 HMTAHNDPLDKYJT-UHFFFAOYSA-N 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000004939 coking Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000000875 corresponding effect Effects 0.000 description 2
- 238000005336 cracking Methods 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 239000000539 dimer Substances 0.000 description 2
- WQOXQRCZOLPYPM-UHFFFAOYSA-N dimethyl disulfide Chemical compound CSSC WQOXQRCZOLPYPM-UHFFFAOYSA-N 0.000 description 2
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 238000005868 electrolysis reaction Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 239000000446 fuel Substances 0.000 description 2
- 238000004868 gas analysis Methods 0.000 description 2
- 238000002523 gelfiltration Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- XLYOFNOQVPJJNP-ZSJDYOACSA-N heavy water Substances [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 239000012263 liquid product Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 239000000395 magnesium oxide Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229910052750 molybdenum Inorganic materials 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 description 2
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- 150000002989 phenols Chemical class 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000001294 propane Substances 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- NDVASEGYNIMXJL-UHFFFAOYSA-N sabinene Chemical compound C=C1CCC2(C(C)C)C1C2 NDVASEGYNIMXJL-UHFFFAOYSA-N 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 230000004580 weight loss Effects 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- FQTLCLSUCSAZDY-UHFFFAOYSA-N (+) E(S) nerolidol Natural products CC(C)=CCCC(C)=CCCC(C)(O)C=C FQTLCLSUCSAZDY-UHFFFAOYSA-N 0.000 description 1
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- NDVASEGYNIMXJL-NXEZZACHSA-N (+)-sabinene Natural products C=C1CC[C@@]2(C(C)C)[C@@H]1C2 NDVASEGYNIMXJL-NXEZZACHSA-N 0.000 description 1
- QEBNYNLSCGVZOH-NFAWXSAZSA-N (+)-valencene Chemical compound C1C[C@@H](C(C)=C)C[C@@]2(C)[C@H](C)CCC=C21 QEBNYNLSCGVZOH-NFAWXSAZSA-N 0.000 description 1
- WTARULDDTDQWMU-RKDXNWHRSA-N (+)-β-pinene Chemical compound C1[C@H]2C(C)(C)[C@@H]1CCC2=C WTARULDDTDQWMU-RKDXNWHRSA-N 0.000 description 1
- WTARULDDTDQWMU-IUCAKERBSA-N (-)-Nopinene Natural products C1[C@@H]2C(C)(C)[C@H]1CCC2=C WTARULDDTDQWMU-IUCAKERBSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- 239000001890 (2R)-8,8,8a-trimethyl-2-prop-1-en-2-yl-1,2,3,4,6,7-hexahydronaphthalene Substances 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- XJPBRODHZKDRCB-CSKARUKUSA-N (3e)-3,7-dimethylocta-1,3,7-triene Chemical compound CC(=C)CC\C=C(/C)C=C XJPBRODHZKDRCB-CSKARUKUSA-N 0.000 description 1
- IHPKGUQCSIINRJ-CSKARUKUSA-N (E)-beta-ocimene Chemical compound CC(C)=CC\C=C(/C)C=C IHPKGUQCSIINRJ-CSKARUKUSA-N 0.000 description 1
- OJISWRZIEWCUBN-QIRCYJPOSA-N (E,E,E)-geranylgeraniol Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CO OJISWRZIEWCUBN-QIRCYJPOSA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- 150000005206 1,2-dihydroxybenzenes Chemical class 0.000 description 1
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- SGVYKUFIHHTIFL-UHFFFAOYSA-N 2-methylnonane Chemical compound CCCCCCCC(C)C SGVYKUFIHHTIFL-UHFFFAOYSA-N 0.000 description 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- 241000195645 Auxenochlorella protothecoides Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- HPHCPEIMXKYQPK-WPDLWGESSA-N C=C(CCC=C(C)C)C1CC=C(C)CC1.CC(C)=CCC/C(C)=C1\C=CC(C)CC1 Chemical compound C=C(CCC=C(C)C)C1CC=C(C)CC1.CC(C)=CCC/C(C)=C1\C=CC(C)CC1 HPHCPEIMXKYQPK-WPDLWGESSA-N 0.000 description 1
- CXENHBSYCFFKJS-VDQVFBMKSA-N C=C/C(C)=C/C/C=C(\C)CCC=C(C)C Chemical compound C=C/C(C)=C/C/C=C(\C)CCC=C(C)C CXENHBSYCFFKJS-VDQVFBMKSA-N 0.000 description 1
- VLCSIBCFYWQTOS-UKTHLTGXSA-N C=CC(=C)CC/C=C(\C)CCC1OC1(C)C Chemical compound C=CC(=C)CC/C=C(\C)CCC1OC1(C)C VLCSIBCFYWQTOS-UKTHLTGXSA-N 0.000 description 1
- JSNRRGGBADWTMC-NTCAYCPXSA-N C=CC(=C)CC/C=C(\C)CCC=C(C)C Chemical compound C=CC(=C)CC/C=C(\C)CCC=C(C)C JSNRRGGBADWTMC-NTCAYCPXSA-N 0.000 description 1
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 1
- 241000195651 Chlorella sp. Species 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000588722 Escherichia Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- 241000371004 Graesiella emersonii Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000235649 Kluyveromyces Species 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 241000195659 Neodesmus pupukensis Species 0.000 description 1
- FQTLCLSUCSAZDY-ATGUSINASA-N Nerolidol Chemical compound CC(C)=CCC\C(C)=C\CC[C@](C)(O)C=C FQTLCLSUCSAZDY-ATGUSINASA-N 0.000 description 1
- BXFSKRYDHFPTPS-UHFFFAOYSA-N OCC(O)CO.CCCCCC=CC(C)=O Chemical compound OCC(O)CO.CCCCCC=CC(C)=O BXFSKRYDHFPTPS-UHFFFAOYSA-N 0.000 description 1
- 241000235648 Pichia Species 0.000 description 1
- 241000195648 Pseudochlorella pringsheimii Species 0.000 description 1
- WTARULDDTDQWMU-UHFFFAOYSA-N Pseudopinene Natural products C1C2C(C)(C)C1CCC2=C WTARULDDTDQWMU-UHFFFAOYSA-N 0.000 description 1
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 241000235013 Yarrowia Species 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- XCPQUQHBVVXMRQ-UHFFFAOYSA-N alpha-Fenchene Natural products C1CC2C(=C)CC1C2(C)C XCPQUQHBVVXMRQ-UHFFFAOYSA-N 0.000 description 1
- MVNCAPSFBDBCGF-UHFFFAOYSA-N alpha-pinene Natural products CC1=CCC23C1CC2C3(C)C MVNCAPSFBDBCGF-UHFFFAOYSA-N 0.000 description 1
- KQAZVFVOEIRWHN-UHFFFAOYSA-N alpha-thujene Natural products CC1=CCC2(C(C)C)C1C2 KQAZVFVOEIRWHN-UHFFFAOYSA-N 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229910052787 antimony Inorganic materials 0.000 description 1
- WATWJIUSRGPENY-UHFFFAOYSA-N antimony atom Chemical compound [Sb] WATWJIUSRGPENY-UHFFFAOYSA-N 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- 229930006722 beta-pinene Natural products 0.000 description 1
- 239000002551 biofuel Substances 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- AOWQMLHKOHRXAD-UHFFFAOYSA-N butane ethane methane pentane propane Chemical compound C.CC.CCC.CCCC.CCCCC AOWQMLHKOHRXAD-UHFFFAOYSA-N 0.000 description 1
- XFWJKVMFIVXPKK-UHFFFAOYSA-N calcium;oxido(oxo)alumane Chemical compound [Ca+2].[O-][Al]=O.[O-][Al]=O XFWJKVMFIVXPKK-UHFFFAOYSA-N 0.000 description 1
- 150000001722 carbon compounds Chemical class 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 239000004568 cement Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- PBAYDYUZOSNJGU-UHFFFAOYSA-N chelidonic acid Natural products OC(=O)C1=CC(=O)C=C(C(O)=O)O1 PBAYDYUZOSNJGU-UHFFFAOYSA-N 0.000 description 1
- 238000003889 chemical engineering Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 239000002283 diesel fuel Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 150000003620 farnesol derivatives Chemical class 0.000 description 1
- LCWMKIHBLJLORW-UHFFFAOYSA-N gamma-carene Natural products C1CC(=C)CC2C(C)(C)C21 LCWMKIHBLJLORW-UHFFFAOYSA-N 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- XWRJRXQNOHXIOX-UHFFFAOYSA-N geranylgeraniol Natural products CC(C)=CCCC(C)=CCOCC=C(C)CCC=C(C)C XWRJRXQNOHXIOX-UHFFFAOYSA-N 0.000 description 1
- OJISWRZIEWCUBN-UHFFFAOYSA-N geranylnerol Natural products CC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCO OJISWRZIEWCUBN-UHFFFAOYSA-N 0.000 description 1
- 239000010649 ginger oil Substances 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000013529 heat transfer fluid Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052741 iridium Inorganic materials 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 229910052747 lanthanoid Inorganic materials 0.000 description 1
- 150000002602 lanthanoids Chemical class 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 238000012269 metabolic engineering Methods 0.000 description 1
- VUZPPFZMUPKLLV-UHFFFAOYSA-N methane;hydrate Chemical compound C.O VUZPPFZMUPKLLV-UHFFFAOYSA-N 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 150000005673 monoalkenes Chemical class 0.000 description 1
- 239000003345 natural gas Substances 0.000 description 1
- WASNIKZYIWZQIP-AWEZNQCLSA-N nerolidol Natural products CC(=CCCC(=CCC[C@@H](O)C=C)C)C WASNIKZYIWZQIP-AWEZNQCLSA-N 0.000 description 1
- 150000007823 ocimene derivatives Chemical class 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 238000011020 pilot scale process Methods 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000012521 purified sample Substances 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- GRWFGVWFFZKLTI-UHFFFAOYSA-N rac-alpha-Pinene Natural products CC1=CCC2C(C)(C)C1C2 GRWFGVWFFZKLTI-UHFFFAOYSA-N 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229910052703 rhodium Inorganic materials 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 229910052707 ruthenium Inorganic materials 0.000 description 1
- 229930006696 sabinene Natural products 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000002594 sorbent Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000001991 steam methane reforming Methods 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 229930006978 terpinene Natural products 0.000 description 1
- 150000003507 terpinene derivatives Chemical class 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- 239000011135 tin Substances 0.000 description 1
- XJPBRODHZKDRCB-UHFFFAOYSA-N trans-alpha-ocimene Natural products CC(=C)CCC=C(C)C=C XJPBRODHZKDRCB-UHFFFAOYSA-N 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 230000005514 two-phase flow Effects 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- WCTNXGFHEZQHDR-UHFFFAOYSA-N valencene Natural products C1CC(C)(C)C2(C)CC(C(=C)C)CCC2=C1 WCTNXGFHEZQHDR-UHFFFAOYSA-N 0.000 description 1
- 229910052720 vanadium Inorganic materials 0.000 description 1
- GPPXJZIENCGNKB-UHFFFAOYSA-N vanadium Chemical compound [V]#[V] GPPXJZIENCGNKB-UHFFFAOYSA-N 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
- IHPKGUQCSIINRJ-UHFFFAOYSA-N β-ocimene Natural products CC(C)=CCC=C(C)C=C IHPKGUQCSIINRJ-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C5/00—Preparation of hydrocarbons from hydrocarbons containing the same number of carbon atoms
- C07C5/02—Preparation of hydrocarbons from hydrocarbons containing the same number of carbon atoms by hydrogenation
- C07C5/03—Preparation of hydrocarbons from hydrocarbons containing the same number of carbon atoms by hydrogenation of non-aromatic carbon-to-carbon double bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C11/00—Aliphatic unsaturated hydrocarbons
- C07C11/21—Alkatrienes; Alkatetraenes; Other alkapolyenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C7/00—Purification; Separation; Use of additives
- C07C7/20—Use of additives, e.g. for stabilisation
-
- C—CHEMISTRY; METALLURGY
- C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
- C10G—CRACKING HYDROCARBON OILS; PRODUCTION OF LIQUID HYDROCARBON MIXTURES, e.g. BY DESTRUCTIVE HYDROGENATION, OLIGOMERISATION, POLYMERISATION; RECOVERY OF HYDROCARBON OILS FROM OIL-SHALE, OIL-SAND, OR GASES; REFINING MIXTURES MAINLY CONSISTING OF HYDROCARBONS; REFORMING OF NAPHTHA; MINERAL WAXES
- C10G45/00—Refining of hydrocarbon oils using hydrogen or hydrogen-generating compounds
-
- C—CHEMISTRY; METALLURGY
- C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
- C10G—CRACKING HYDROCARBON OILS; PRODUCTION OF LIQUID HYDROCARBON MIXTURES, e.g. BY DESTRUCTIVE HYDROGENATION, OLIGOMERISATION, POLYMERISATION; RECOVERY OF HYDROCARBON OILS FROM OIL-SHALE, OIL-SAND, OR GASES; REFINING MIXTURES MAINLY CONSISTING OF HYDROCARBONS; REFORMING OF NAPHTHA; MINERAL WAXES
- C10G53/00—Treatment of hydrocarbon oils, in the absence of hydrogen, by two or more refining processes
- C10G53/02—Treatment of hydrocarbon oils, in the absence of hydrogen, by two or more refining processes plural serial stages only
- C10G53/04—Treatment of hydrocarbon oils, in the absence of hydrogen, by two or more refining processes plural serial stages only including at least one extraction step
-
- C—CHEMISTRY; METALLURGY
- C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
- C10G—CRACKING HYDROCARBON OILS; PRODUCTION OF LIQUID HYDROCARBON MIXTURES, e.g. BY DESTRUCTIVE HYDROGENATION, OLIGOMERISATION, POLYMERISATION; RECOVERY OF HYDROCARBON OILS FROM OIL-SHALE, OIL-SAND, OR GASES; REFINING MIXTURES MAINLY CONSISTING OF HYDROCARBONS; REFORMING OF NAPHTHA; MINERAL WAXES
- C10G53/00—Treatment of hydrocarbon oils, in the absence of hydrogen, by two or more refining processes
- C10G53/02—Treatment of hydrocarbon oils, in the absence of hydrogen, by two or more refining processes plural serial stages only
- C10G53/08—Treatment of hydrocarbon oils, in the absence of hydrogen, by two or more refining processes plural serial stages only including at least one sorption step
-
- C—CHEMISTRY; METALLURGY
- C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
- C10G—CRACKING HYDROCARBON OILS; PRODUCTION OF LIQUID HYDROCARBON MIXTURES, e.g. BY DESTRUCTIVE HYDROGENATION, OLIGOMERISATION, POLYMERISATION; RECOVERY OF HYDROCARBON OILS FROM OIL-SHALE, OIL-SAND, OR GASES; REFINING MIXTURES MAINLY CONSISTING OF HYDROCARBONS; REFORMING OF NAPHTHA; MINERAL WAXES
- C10G67/00—Treatment of hydrocarbon oils by at least one hydrotreatment process and at least one process for refining in the absence of hydrogen only
- C10G67/02—Treatment of hydrocarbon oils by at least one hydrotreatment process and at least one process for refining in the absence of hydrogen only plural serial stages only
- C10G67/04—Treatment of hydrocarbon oils by at least one hydrotreatment process and at least one process for refining in the absence of hydrogen only plural serial stages only including solvent extraction as the refining step in the absence of hydrogen
-
- C—CHEMISTRY; METALLURGY
- C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
- C10G—CRACKING HYDROCARBON OILS; PRODUCTION OF LIQUID HYDROCARBON MIXTURES, e.g. BY DESTRUCTIVE HYDROGENATION, OLIGOMERISATION, POLYMERISATION; RECOVERY OF HYDROCARBON OILS FROM OIL-SHALE, OIL-SAND, OR GASES; REFINING MIXTURES MAINLY CONSISTING OF HYDROCARBONS; REFORMING OF NAPHTHA; MINERAL WAXES
- C10G67/00—Treatment of hydrocarbon oils by at least one hydrotreatment process and at least one process for refining in the absence of hydrogen only
- C10G67/02—Treatment of hydrocarbon oils by at least one hydrotreatment process and at least one process for refining in the absence of hydrogen only plural serial stages only
- C10G67/06—Treatment of hydrocarbon oils by at least one hydrotreatment process and at least one process for refining in the absence of hydrogen only plural serial stages only including a sorption process as the refining step in the absence of hydrogen
-
- C—CHEMISTRY; METALLURGY
- C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
- C10L—FUELS NOT OTHERWISE PROVIDED FOR; NATURAL GAS; SYNTHETIC NATURAL GAS OBTAINED BY PROCESSES NOT COVERED BY SUBCLASSES C10G, C10K; LIQUEFIED PETROLEUM GAS; ADDING MATERIALS TO FUELS OR FIRES TO REDUCE SMOKE OR UNDESIRABLE DEPOSITS OR TO FACILITATE SOOT REMOVAL; FIRELIGHTERS
- C10L1/00—Liquid carbonaceous fuels
- C10L1/04—Liquid carbonaceous fuels essentially based on blends of hydrocarbons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2523/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group C07C2521/00
- C07C2523/38—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group C07C2521/00 of noble metals
- C07C2523/40—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group C07C2521/00 of noble metals of the platinum group metals
- C07C2523/44—Palladium
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2523/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group C07C2521/00
- C07C2523/70—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group C07C2521/00 of the iron group metals or copper
- C07C2523/74—Iron group metals
- C07C2523/755—Nickel
-
- C—CHEMISTRY; METALLURGY
- C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
- C10G—CRACKING HYDROCARBON OILS; PRODUCTION OF LIQUID HYDROCARBON MIXTURES, e.g. BY DESTRUCTIVE HYDROGENATION, OLIGOMERISATION, POLYMERISATION; RECOVERY OF HYDROCARBON OILS FROM OIL-SHALE, OIL-SAND, OR GASES; REFINING MIXTURES MAINLY CONSISTING OF HYDROCARBONS; REFORMING OF NAPHTHA; MINERAL WAXES
- C10G2300/00—Aspects relating to hydrocarbon processing covered by groups C10G1/00 - C10G99/00
- C10G2300/10—Feedstock materials
- C10G2300/1011—Biomass
-
- C—CHEMISTRY; METALLURGY
- C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
- C10G—CRACKING HYDROCARBON OILS; PRODUCTION OF LIQUID HYDROCARBON MIXTURES, e.g. BY DESTRUCTIVE HYDROGENATION, OLIGOMERISATION, POLYMERISATION; RECOVERY OF HYDROCARBON OILS FROM OIL-SHALE, OIL-SAND, OR GASES; REFINING MIXTURES MAINLY CONSISTING OF HYDROCARBONS; REFORMING OF NAPHTHA; MINERAL WAXES
- C10G2300/00—Aspects relating to hydrocarbon processing covered by groups C10G1/00 - C10G99/00
- C10G2300/10—Feedstock materials
- C10G2300/1037—Hydrocarbon fractions
- C10G2300/1048—Middle distillates
- C10G2300/1055—Diesel having a boiling range of about 230 - 330 °C
-
- C—CHEMISTRY; METALLURGY
- C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
- C10G—CRACKING HYDROCARBON OILS; PRODUCTION OF LIQUID HYDROCARBON MIXTURES, e.g. BY DESTRUCTIVE HYDROGENATION, OLIGOMERISATION, POLYMERISATION; RECOVERY OF HYDROCARBON OILS FROM OIL-SHALE, OIL-SAND, OR GASES; REFINING MIXTURES MAINLY CONSISTING OF HYDROCARBONS; REFORMING OF NAPHTHA; MINERAL WAXES
- C10G2300/00—Aspects relating to hydrocarbon processing covered by groups C10G1/00 - C10G99/00
- C10G2300/20—Characteristics of the feedstock or the products
- C10G2300/201—Impurities
-
- C—CHEMISTRY; METALLURGY
- C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
- C10G—CRACKING HYDROCARBON OILS; PRODUCTION OF LIQUID HYDROCARBON MIXTURES, e.g. BY DESTRUCTIVE HYDROGENATION, OLIGOMERISATION, POLYMERISATION; RECOVERY OF HYDROCARBON OILS FROM OIL-SHALE, OIL-SAND, OR GASES; REFINING MIXTURES MAINLY CONSISTING OF HYDROCARBONS; REFORMING OF NAPHTHA; MINERAL WAXES
- C10G2300/00—Aspects relating to hydrocarbon processing covered by groups C10G1/00 - C10G99/00
- C10G2300/40—Characteristics of the process deviating from typical ways of processing
- C10G2300/4081—Recycling aspects
-
- C—CHEMISTRY; METALLURGY
- C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
- C10G—CRACKING HYDROCARBON OILS; PRODUCTION OF LIQUID HYDROCARBON MIXTURES, e.g. BY DESTRUCTIVE HYDROGENATION, OLIGOMERISATION, POLYMERISATION; RECOVERY OF HYDROCARBON OILS FROM OIL-SHALE, OIL-SAND, OR GASES; REFINING MIXTURES MAINLY CONSISTING OF HYDROCARBONS; REFORMING OF NAPHTHA; MINERAL WAXES
- C10G2300/00—Aspects relating to hydrocarbon processing covered by groups C10G1/00 - C10G99/00
- C10G2300/80—Additives
- C10G2300/802—Diluents
-
- C—CHEMISTRY; METALLURGY
- C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
- C10G—CRACKING HYDROCARBON OILS; PRODUCTION OF LIQUID HYDROCARBON MIXTURES, e.g. BY DESTRUCTIVE HYDROGENATION, OLIGOMERISATION, POLYMERISATION; RECOVERY OF HYDROCARBON OILS FROM OIL-SHALE, OIL-SAND, OR GASES; REFINING MIXTURES MAINLY CONSISTING OF HYDROCARBONS; REFORMING OF NAPHTHA; MINERAL WAXES
- C10G2400/00—Products obtained by processes covered by groups C10G9/00 - C10G69/14
- C10G2400/22—Higher olefins
-
- C—CHEMISTRY; METALLURGY
- C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
- C10L—FUELS NOT OTHERWISE PROVIDED FOR; NATURAL GAS; SYNTHETIC NATURAL GAS OBTAINED BY PROCESSES NOT COVERED BY SUBCLASSES C10G, C10K; LIQUEFIED PETROLEUM GAS; ADDING MATERIALS TO FUELS OR FIRES TO REDUCE SMOKE OR UNDESIRABLE DEPOSITS OR TO FACILITATE SOOT REMOVAL; FIRELIGHTERS
- C10L1/00—Liquid carbonaceous fuels
- C10L1/10—Liquid carbonaceous fuels containing additives
- C10L1/14—Organic compounds
- C10L1/16—Hydrocarbons
- C10L1/1608—Well defined compounds, e.g. hexane, benzene
-
- C—CHEMISTRY; METALLURGY
- C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
- C10L—FUELS NOT OTHERWISE PROVIDED FOR; NATURAL GAS; SYNTHETIC NATURAL GAS OBTAINED BY PROCESSES NOT COVERED BY SUBCLASSES C10G, C10K; LIQUEFIED PETROLEUM GAS; ADDING MATERIALS TO FUELS OR FIRES TO REDUCE SMOKE OR UNDESIRABLE DEPOSITS OR TO FACILITATE SOOT REMOVAL; FIRELIGHTERS
- C10L1/00—Liquid carbonaceous fuels
- C10L1/10—Liquid carbonaceous fuels containing additives
- C10L1/14—Organic compounds
- C10L1/18—Organic compounds containing oxygen
- C10L1/182—Organic compounds containing oxygen containing hydroxy groups; Salts thereof
- C10L1/183—Organic compounds containing oxygen containing hydroxy groups; Salts thereof at least one hydroxy group bound to an aromatic carbon atom
- C10L1/1832—Organic compounds containing oxygen containing hydroxy groups; Salts thereof at least one hydroxy group bound to an aromatic carbon atom mono-hydroxy
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P30/00—Technologies relating to oil refining and petrochemical industry
- Y02P30/20—Technologies relating to oil refining and petrochemical industry using bio-feedstock
Definitions
- Petroleum-derived compounds and compositions are found in a variety of products ranging from plastics to household cleaners as well as fuels. Given the environmental impact of these compositions, there is an increasing demand for more renewable and sustainable alternatives.
- isoprenoids comprise a diverse class of compounds with over 50,000 members, and have a variety of uses including as specialty chemicals, pharmaceuticals and even fuels.
- Most isoprenoid compounds conventionally have been synthesized from petroleum sources or extracted from plant sources.
- a third option exists which is capable of making a desired isoprenoid compound using microbial cells.
- Systems for making petroleum-derived compounds and compositions have been described, for example, by U.S. Pat. No. 7,399,323; U.S. Patent Publication No. 2008/0274523; and PCT Publication Nos. WO 2007/140339, WO 2008/140492, WO 2008/133658, and WO 2009/014636.
- a method of stabilizing a microbial-derived olefin comprising separating immiscible olefin from a mixture comprising an aqueous solution, microbial cells and immiscible olefin thereby forming a crude olefin composition; purifying the crude olefin composition thereby forming a purified olefin composition; and adding a phenolic antioxidant to the purified olefin composition to form a stabilized purified microbial-derived olefin composition.
- the purification step is selected from fractional distillation, flash distillation, adsorption, liquid chromatography, solvent extraction and a combination thereof.
- the immiscible olefin comprises farnesene.
- a stabilized microbial olefin composition comprising an immiscible olefin in an amount at least about 93% by weight of the composition; and a phenolic antioxidant in an amount at least about 0.0001% by weight of the composition.
- a stabilized microbial olefin composition comprises an immiscible olefin in an amount at least about 93% by weight of the composition; and a phenolic antioxidant in an amount from about 0.0001-0.5% by weight of the composition.
- a stabilized microbial olefin composition comprises an immiscible olefin in an amount at least about 93% by weight of the composition; and a phenolic antioxidant in an amount from about 0.0001-0.1%, 0.0005-0.1%, 0.0005-0.01%, 0.0005-0.05 or 0.001 to 0.01% by weight of the composition.
- a stabilized microbial olefin composition comprising an immiscible olefin in an amount at least about 93% by weight of the composition; and a phenolic antioxidant in an amount at least about 0.001% by weight of the composition.
- provided herein is a method for hydrogenation of an immiscible olefin comprising reacting an immiscible olefin with hydrogen in the presence of a hydrogenation catalyst such that hydrogen saturates at least one double bond in the immiscible olefin and wherein the hydrogenation reaction occurs at room temperature or higher temperature.
- the hydrogenation reaction provided herein occurs a temperature that is 20° C. or greater.
- the hydrogenation reaction provided herein occurs a temperature of about 20° C., 30° C., 40° C., 50° C., 60° C., 70° C., 80° C., 90° C., 100° C. or greater.
- the hydrogenation reaction provided herein occurs a temperature from about 20-100° C., 40-100° C., 50-100° C., 75-100° C., 90-100° C., 90-125° C., 80-125° C. or greater.
- a method for hydrogenation of an immiscible olefin comprising reacting an immiscible olefin with hydrogen in the presence of a hydrogenation catalyst such that hydrogen saturates at least one double bond in the immiscible olefin and wherein the hydrogenation reaction occurs at a temperature greater than about 100° C.
- the hydrogenation reaction is conducted in a fixed bed reactor.
- a method for hydrogenating an immiscible olefin comprising: a) providing a feed stream to the inlet of a fixed bed reactor wherein the feed stream comprises an immiscible olefin and a diluent composition; b) contacting the feed stream with hydrogen in the presence of a hydrogenation catalyst at a temperature greater than about 100° C.
- a purified farnesene composition comprising a microbial-derived mixture comprising farnesene in an amount that is equal to or greater than about 93% by weight and the following compounds each of which is present in an amount that is equal to or greater than about 0.1% by weight: bisabolene, zingiberene, farnesol, and farnesene epoxide; and a phenolic antioxidant in an amount that is at least about 0.001% by weight.
- provided herein are processes and systems for catalytic hydrogenation of farnesene to obtain farnesane.
- a process for hydrogenation of farnesene by contacting a farnesene feed and hydrogen with a catalyst.
- FIG. 1 is a plot of the rate of hydrogenation versus hydrogen equivalents during a hydrogenation reaction of commercially available trans- ⁇ farnesene (Bedoukian Research).
- data for hydrogenation of trans- ⁇ farnesene with ⁇ -tocopherol is represented by ⁇
- data for hydrogenation of trans- ⁇ farnesene without ⁇ -tocopherol is represented by ⁇
- data for hydrogenation of trans- ⁇ farnesene without ⁇ -tocopherol plus additional purification from silica filtration to remove impurities is represented by x and ⁇ , respectively.
- the rate of observed hydrogenation as a function of hydrogen equivalent appears to be limited by the ⁇ -tocopherol added by Bedoukian to stabilize farnesene.
- FIG. 2 is a plot comparing rate versus hydrogen equivalent for two lots of commercially available farnesene that were silica filtered to remove ⁇ -tocopherol, represented by ⁇ and ⁇ in the plot, along with a commercially available lot of farnesene that was silica filtered to remove ⁇ -tocopherol, stored at 20° C. for ten days and then hydrogenated, represented by ⁇ .
- the hydrogenation reaction proceeded with an average value of 10.7 ⁇ 1.9 minutes per hydrogen equivalent (9.3 minutes per hydrogen equivalent, data represented by ⁇ in the plot, and 12.1 minutes per hydrogen equivalent, data represented by ⁇ in the plot, individually).
- the hydrogenation rate of commercially available farnesene in which ⁇ -tocopherol was removed, stored at 20° C. for ten days, and then hydrogenated (data represented by ⁇ in the plot) was 14.9 minutes per hydrogen equivalent.
- the hydrogenation conditions were 5% Pd/C at 60 psia at 100° C.
- FIGS. 3A and 3B are plots of rate and temperature versus hydrogen equivalents during a hydrogenation reaction of microbially-derived farnesene and commercially available farnesene (with ⁇ -tocopherol removed), respectively, under identical reaction conditions (5% Pd/C at 60 psia at 100° C.).
- data for rate is represented by ⁇
- data for temperature is represented by ⁇ .
- FIG. 4 is a plot showing the hydrogenation time/hydrogen equivalent versus storage time for various lots of microbial-derived farnesene at 4° C.
- the hydrogenation conditions were 5% Pd/C at 60 psia at 100° C.
- data for crude farnesene composition is represented by ⁇
- data for silica filtered farnesene composition is represented by ⁇
- data for crude farnesene composition with 100 ppm 4-tert-butylcatechol is represented by ⁇ .
- FIG. 5 is a plot showing peroxide concentration and hydrogenation time/hydrogen equivalent versus storage time for various lots of microbial-derived farnesene at 4° C.
- the hydrogenation conditions were 5% Pd/C at 60 psia at 100° C.
- dotted lines represent hydrogenation rates and solid lines represent peroxide concentration.
- the data for crude farnesene composition is represented by ⁇
- data for silica filtered farnesene composition is represented by ⁇
- data for purified farnesene composition with 100 ppm 4-tert-butylcatechol is represented by ⁇ .
- FIG. 6 is a plot of apparent hydrogenation rates for farnesene at 0.5, 1, 2, and 3 equivalents of hydrogen at 100° C. and 50 mg of catalyst loading.
- FIG. 7 is a plot of hydrogenation uptake rate for various purified olefin compositions over periods of time to test catalyst life at the process LHSV (Liquid Hourly Space Velocity) of 12 ml of olefin fed to process/mL catalyst per hour.
- the hydrogenation conditions were: 20% Ni/Al 2 O 3 catalyst diluted 4 ⁇ with glass beads hydrogenating a composition of 5% farnesene and 95% decane at a pressure of 500 psig.
- the farnesene in the farnesene composition is a purified microbial-derived farnesene and the hydrogenation reaction occurs at 100° C. As it can be seen, the catalyst degrades rapidly over one day and continues to deactivate over three days.
- This catalyst could be recovered by increasing the temperature. This is shown by the second part of the plot which shows that the hydrogen uptake can be recovered almost fully by simply increasing the temperature to a temperature greater than 100° C. (in this case 150° C.).
- the third part of the plot demonstrates catalyst deactivation as the chemically-derived counterpart could be hydrogenated at 100° C. with no catalyst deactivation.
- FIG. 8 is a plot of hydrogenation uptake rate for farnesene versus farnesene concentration showing that hydrogenation of farnesene displays zero-order kinetics and no substrate mass transfer resistance.
- FIG. 9 is a schematic of an exemplary hydrogenation system for the practice of an embodiment of the hydrogenation process provided herein.
- FIG. 10 shows the final product composition from various hydrogenations of limonene in a batch reactor.
- microbial-derived olefin refers a compound with at least one double bound that is made by microbial cells (both recombinant as well as naturally occurring).
- the microbial-derived olefin is a hydrocarbon with at least one carbon-carbon double bond.
- the microbial-derived olefin is an isoprenoid.
- the microbial-derived olefin is a C 5 -C 20 isoprenoid.
- the microbial-derived olefin is a C 10 -C 15 isoprenoid.
- the microbial-derived olefin is an isoprenoid with at least one carbon-carbon double bond. In additional embodiments, the microbial-derived olefin is a C 5 -C 20 isoprenoid or a C 10 -C 15 isoprenoid with at least one carbon-carbon double bond.
- miscible olefin refers to a microbial-derived olefin that is immiscible with water.
- crude olefin composition refers to a composition comprising an immiscible olefin wherein the olefin is present in the composition in an amount greater than about 50% by weight but is less than about 92% by weight.
- purified olefin composition refers to a composition comprising an immiscible olefin wherein the olefin is present in the composition in an amount equal to or greater than about 93% by weight. In certain embodiments, the olefin is present in an amount equal to or greater than about 95% by weight.
- stabilized purified olefin composition refers to a composition comprising a purified olefin composition and a phenolic antioxidant.
- phenolic antioxidant refers to an antioxidant that is a phenol or a phenol derivative, wherein the phenol derivative contains an unfused phenyl ring with one or more hydroxyl substitutents.
- the term also includes polyphenols.
- Illustrative examples of a phenolic antioxidant include: resveratrol; 3-tert-butyl-4-hydroxyanisole; 2-tert-butyl-4-hydroxyanisole; 4-tert-butylcatechol (which is also known as TBC); 2,4-dimethyl-6-tert-butylphenol; and 2,6-di-tert-butyl-4-methylphenol (which is also known as butylhydroxytoluene or BHT). Additional examples of phenolic antioxidants are disclosed in U.S. Pat. No. 7,179,311.
- hydrogenated immiscible olefin refers to a partially hydrogenated immiscible olefin. In other words, an immiscible olefin that had a plurality of double bonds wherein at least one of its double bonds has been hydrogenated leaving at least one double bond remaining.
- saturated immiscible olefin refers to a fully hydrogenated counterpart of an immiscible olefin.
- ⁇ -Farnesene refers to a compound having the following structure:
- the ⁇ -farnesene comprises a substantially pure isomer of ⁇ -farnesene.
- the ⁇ -farnesene comprises a mixture of isomers, such as cis-trans isomers.
- the amount of each of the isomers in the ⁇ -farnesene mixture is independently from about 0.1 wt. % to about 99.9 wt. %, from about 0.5 wt. % to about 99.5 wt. %, from about 1 wt. % to about 99 wt. %, from about 5 wt. % to about 95 wt. %, from about 10 wt. % to about 90 wt. %, from about 20 wt. % to about 80 wt. %, based on the total weight of the ⁇ -farnesene mixture.
- ⁇ -Farnesene refers to a compound having the following structure:
- the ⁇ -farnesene comprises a substantially pure isomer of ⁇ -farnesene.
- the ⁇ -farnesene comprises a mixture of isomers, such as cis-trans isomers.
- the amount of each of the isomers in the ⁇ -farnesene mixture is independently from about 0.1 wt. % to about 99.9 wt. %, from about 0.5 wt. % to about 99.5 wt. %, from about 1 wt. % to about 99 wt. %, from about 5 wt. % to about 95 wt. %, from about 10 wt. % to about 90 wt. %, from about 20 wt. % to about 80 wt. %, based on the total weight of the ⁇ -farnesene mixture.
- Frnesene refers to ⁇ -farnesene, ⁇ -farnesene or a mixture thereof.
- Hydrogenated farnesene refers to ⁇ -farnesene, ⁇ -farnesene or a mixture thereof wherein at least one double bond is hydrogenated.
- hydrogenated farnesene emcompasses, for example, ⁇ -farnesene wherein one, two, three or four double bonds are hydrogenated, ⁇ -farnesene wherein one, two, three or four double bonds are hydrogenated, and a mixture thereof.
- Hydrogenated farnesene is obtained by partial hydrogenation of farnesene.
- “Farnesane” refers to a compound having structure:
- the farnesane comprises a substantially pure stereoisomer of farnesane.
- the farnesane comprises a mixture of stereoisomers, such as enantiomers and diastereoisomers, of farnesane.
- the amount of each of the stereoisomers in the farnesane mixture is independently from about 0.1 wt. % to about 99.9 wt. %, from about 0.5 wt. % to about 99.5 wt. %, from about 1 wt. % to about 99 wt. %, from about 5 wt. % to about 95 wt. %, from about 10 wt. % to about 90 wt. %, from about 20 wt. % to about 80 wt. %, based on the total weight of the farnesane mixture.
- unsaturated farnesane refers to one or more farnesane molecules containing one or more double bonds.
- monounsaturated farnesane refers to one or more farnesane molecules containing one double bond.
- Unsaturated farnesane is obtained by partial hydrogenation of farnesene.
- “Farnesene epoxide” refers to a compound having structure:
- “Farnesol” refers to a compound having the structure:
- “Bisabolane” refers to a compound having the following structure:
- farnesene feed refers to a mixture of farnesene and a diluent, such as farnesane.
- product fraction refers to a fraction of a product composition comprising a hydrogenated immiscible olefin, such as hydrogenated farnesene, that is separated from an effluent of a hydrogenation reaction provided herein.
- the product fraction can undergo further hydrogenation in a secondary reactor to remove residual unsaturation to obtain a saturated product, e.g., farnesane, or can be used without further hydrogenation, for example in biofuels, without further treatment.
- reactant stream refers to a mixture of an immiscible olefin feed and hydrogen.
- process(es) refers to method(s) disclosed herein that is (are) useful for hydrogenation of a microbial-derived olefin where at least one double bond of the olefin is converted into a single bond by the addition of hydrogen. Modifications to the methods disclosed herein (e.g., starting materials, reagents, temperatures, pressure) are also encompassed.
- recycling fraction refers to a fraction of a product composition that is separated from an effluent of a hydrogenation reaction provided herein and recycled as a diluent in the hydrogenation reaction.
- reaction that is “substantially complete” or is driven to “substantial completion” means that the reaction contains more than about 80% desired product by percent yield, more than about 90% desired product by percent yield, more than about 95% desired product by percent yield, or more than about 97% desired product by percent yield.
- axial temperature rise refers to the increase in temperature during a hydrogenation reaction in a cocurrent downflow reactor as a reactant stream flows from the top of the reactor to the bottom of the reactor in presence of a catalyst.
- R R L +k*(R U ⁇ R L ), wherein k is a variable ranging from 1 percent to 100 percent with a 1 percent increment, i.e., k is 1 percent, 2 percent, 3 percent, 4 percent, 5 percent, . . . , 50 percent, 51 percent, 52 percent, . . . , 95 percent, 96 percent, 97 percent, 98 percent, 99 percent, or 100 percent.
- any numerical range defined by two R numbers as defined in the above is also specifically disclosed.
- microbial olefin compositions and methods for stabilizing and hydrogenating the same can be made using any technique deemed suitable by one of skill in the art.
- Useful exemplary microbial methods for making olefinic isoprenoids are described in U.S. Pat. No. 7,399,323; U.S. Patent Publication No. 2008/0274523; and PCT Publication Nos. WO 2007/140339, WO 2008/140492, WO 2008/133658, and WO 2009/014636, all incorporated by reference in their entireties.
- Useful exemplary microbial methods for making fatty-acid derived olefins are described in U.S. Patent Publication No. 2009/0047721; and PCT Publication Nos. WO 2008/113041 and WO 2008/151149, all incorporated by reference in their entireties.
- a method of stabilizing a microbial-derived olefin comprises adding a phenolic antioxidant to the microbial-derived composition.
- the method comprises:
- the method further comprises purifying the olefin composition, before and/or after step b) to form a purified olefin composition.
- the method comprises:
- the method further comprises adding a phenolic antioxidant to the crude olefin composition before the purification step. In certain embodiments, the method further comprises adding a phenolic antioxidant to the olefin composition before and after the purification step.
- the method further comprises contacting the purified olefin composition with hydrogen in the presence of a hydrogenation catalyst thereby forming a hydrogenated counterpart to the immiscible olefin wherein at least one carbon-carbon double bond becomes saturated by the addition of hydrogen.
- the olefin is derived from microbial cells.
- the microbial cells are bacteria.
- the microbial cells belong to the genera Escherichia, Bacillus, Lactobacillus .
- the microbial cells are E. coli .
- the microbial cells are fungi.
- the microbial cells are yeast.
- the microbial cells are Kluyveromyces, Pichia, Saccharomyces , or Yarrowia .
- the microbial cells are S. cerevisiae .
- the microbial cells are algae.
- the microbial cells are Chlorella minutissima, Chlorella emersonii, Chloerella sorkiniana, Chlorella ellipsoidea, Chlorella sp., or Chlorella protothecoides.
- the immiscible olefin is a hydrocarbon. In certain embodiments, the immiscible olefin is a fatty acid or a fatty acid-derivative. In further embodiments, the immiscible olefin is an isoprenoid. In still further embodiments, the immiscible olefin is a C 5 -C 20 isoprenoid. In certain embodiments, the immiscible olefin is a C 10 -C 15 isoprenoid.
- the immiscible olefin is selected from careen, geraniol, linalool, limonene, myrcene, ocimene, pinene, sabinene, terpinene, terpinolene, amorphadiene, farnesene, farnesol, nerolidol, valencene, and geranylgeraniol.
- the immiscible olefin is myrcene, ⁇ -ocimene, ⁇ -ocimene, ⁇ -pinene, ⁇ -pinene, amorphadiene, ⁇ -farnesene or ⁇ -farnesene. In certain embodiments, the immiscible olefin is ⁇ -farnesene, ⁇ -farnesene, or a mixture thereof.
- the purification step comprises fractional distillation. In certain embodiments, the purification step comprises flash distillation (which is also known as flash or partial evaporation). In certain embodiments, the purification step comprises adsorption. In certain embodiments, the purification step comprises silica gel filtration. In certain embodiments, the purification step comprises alumina treatment. In additional embodiments, the purification step comprises liquid chromatography. In further embodiments, the purification step comprises solvent extraction.
- the impurities removed in the purification step include, for example, cold insolubles, such as mono-, di-, and triglycerides.
- the cold insolubles further includes ergosterol and squalene.
- the impurities removed in the purification step include, for example, chemicals added in upstream processing, such as antifoams, deemulsifiers and other chemicals.
- the cold insolubles further includes ergosterol and squalene.
- the phenolic antioxidant is a polyphenol. In certain embodiments, the phenolic antioxidant is resveratrol. In certain embodiments, the phenolic antioxidant is a monophenol. In certain embodiments, the phenolic antioxidant is selected from: 3-tert-butyl-4-hydroxyanisole; 2-tert-butyl-4-hydroxyanisole; 2,4-dimethyl-6-tert-butylphenol; and 2,6-di-tert-butyl-4-methylphenol. In certain embodiments, the phenolic antioxidant is a catechol. In further embodiments, the phenolic antioxidant is 4-tert-butylcatechol.
- the phenolic antioxidant is present in an amount that is at least about 0.0001% by weight of the composition. In certain embodiments, the phenolic antioxidant is present in an amount that is between about 0.0001% and about 0.5% by weight of the composition. In certain embodiments, the phenolic antioxidant is present in an amount that is between about 0.0001% and about 0.01% by weight of the composition. In certain embodiments, the phenolic antioxidant is present in an amount that is between about 0.0005 to 0.01%, 0.001 to 0.01%, or 0.005 to 0.01% by weight of the composition. In certain embodiments, the phenolic antioxidant is present in an amount that is at least about 0.005% by weight of the composition.
- the phenolic antioxidant is present in an amount that is between about 0.005% and about 0.5% by weight of the composition. In further embodiments, the phenolic antioxidant is present in an amount that is at least about 0.01% by weight of the composition. In additional embodiments, the phenolic antioxidant is present in an amount that is between about 0.05% and about 0.3% by weight of the composition. In certain embodiments, the phenolic antioxidant is present in an amount that is at least about 0.0001%, 0.0005%, 0.001%, 0.005%, 0.01%, 0.05%. 0.1% or 0.5%. In certain embodiments, the phenolic antioxidant is present in an amount that is greater than about 0.5% by weight of the composition.
- a stabilized microbial olefin composition comprises:
- phenolic antioxidant wherein the phenolic antioxidant is present in an amount that is at least about 0.001% by weight of the composition.
- the phenolic antioxidant is present in an amount that is at least about 0.0001% by weight of the composition. In certain embodiments, the phenolic antioxidant is present in an amount that is between about 0.0001% and about 0.5% by weight of the composition. In certain embodiments, the phenolic antioxidant is present in an amount that is between about 0.0001% and about 0.01% by weight of the composition. In certain embodiments, the phenolic antioxidant is present in an amount that is between about 0.0005 to 0.01%, 0.001 to 0.01%, or 0.005 to 0.01% by weight of the composition. In certain embodiments, the phenolic antioxidant is present in an amount that is at least about 0.005% by weight of the composition.
- the phenolic antioxidant is present in an amount that is between about 0.005% and about 0.5% by weight of the composition. In further embodiments, the phenolic antioxidant is present in an amount that is at least about 0.01% by weight of the composition. In additional embodiments, the phenolic antioxidant is present in an amount that is between about 0.05% and about 0.3% by weight of the composition. In certain embodiments, the phenolic antioxidant is present in an amount that is at least about 0.0001%, 0.0005%, 0.001%, 0.005%, 0.01%, 0.05%. 0.1% or 0.5%. In certain embodiments, the phenolic antioxidant is present in an amount that is greater than about 0.5% by weight of the composition.
- the immiscible olefin in the composition is present in an amount that is at least about 93%, 94%, 95%, 96%, 97% or greater by weight of the composition.
- the immiscible olefin in the composition comprises farnesene in an amount that is at least about 50%, 60%, 70%, 80%, 90% 93%, 95%, 97%, 99% or greater by weight of the composition.
- a composition of microbial-derived olefin and a composition of its chemically synthesized counterpart can have different properties due to the different impurities contained therein. In some cases, these differences are immaterial to the desired end use. But, in certain situations, these differences can have a material impact.
- the methods and compositions provided herein relate to one of these situations. As it will be described more fully below, the methods and compositions can significantly decrease the hydrogenation reaction time of a microbial-derived olefin. The improvements from using the methods and processes can result in cost savings due to shorter hydrogenation times, milder reaction conditions, and longer catalyst lifetimes. Although the following focuses on the hydrogenation of farnesene for the purposes of illustration, similar results are obtained with other microbial-derived immiscible olefins.
- FIG. 1 shows the plot of the rate of hydrogenation versus the hydrogen equivalents during a hydrogenation reaction of the Bedoukian 90% pure trans ⁇ -farnesene.
- ⁇ -tocopherol is removed, for example by silica gel filtration, then the sample hydrogenated readily.
- a highly pure 98% ⁇ -farnesene composition as well a mixture of a mixture of ⁇ -farnesene and ⁇ -farnesene behaved similarly.
- the hydrogenation reaction (regardless of the purity level of the farnesene sample) was impaired but if removed, the reaction proceeded readily under mild hydrogenation conditions.
- a potential stability issue was created from the removal of ⁇ -tocopherol from commercially-obtained farnesene
- the stability of a tocopherol-free farnesene was investigated. As shown by FIG. 2 , a tocopherol-free farnesene was found to be stable at 20° C. for at least 10 days. While the hydrogenation time was slightly higher (14.9 minutes per hydrogen equivalent), it was nevertheless comparable to the different lots of farnesene in which the ⁇ -tocopherol was removed just prior to hydrogenation (9.3 minutes per hydrogen equivalent and 12.1 minutes per hydrogen equivalent in two lots providing an average value of 10.7 ⁇ 1.9 minutes per hydrogen equivalent). The hydrogenation conditions were 5% Pd/C at 60 psia at 100° C.
- FIGS. 3A and 3B With the baseline established, microbial-derived ⁇ -farnesene (95% pure by GCMS) was hydrogenated and compared with its chemically synthesized counterpart. The results are shown in FIGS. 3A and 3B . As it can be seen in FIGS. 3A and 3B , the microbial-derived farnesene contained one or more inhibitors that impeded the progress of the hydrogenation reaction.
- FIG. 4 is a plot showing the hydrogenation times under mild hydrogenation conditions (5% Pd/C at 60 psia at 100° C.) for the various microbial farnesene as a function of storage time.
- mild hydrogenation conditions 5% Pd/C at 60 psia at 100° C.
- Microbial cells that were genetically modified to make farnesene were grown in culture medium, as described for example, by U.S. Pat. No. 7,399,323 and PCT Publication No. WO 2007/139924.
- the cells were separated from the culture medium and the resulting broth was centrifuged to purify immiscible organic layer from the aqueous medium.
- the resulting organic layer is the crude olefin composition wherein the immiscible olefin is present in the composition in an amount greater than about 50% by weight but is less than about 92% by weight.
- the crude olefin composition includes components which can precipitate from solution at cold temperatures (e.g. 4° C.).
- cold insolubles include various glycerides such as mono-, di-, and triglycerides.
- the immiscible olefin is produced in yeast, the cold insolubles also include ergosterol and squalene.
- the crude olefin composition is a crude ⁇ -farnesene composition.
- removing the cells and separating the immiscible layer from the aqueous broth yields a crude ⁇ -farnesene composition of about 90% purity by GCMS.
- the crude olefin composition can be further purified to a composition comprising an immiscible olefin wherein the olefin is present in the composition in an amount equal to or greater than about 93% by weight. In certain embodiments, the olefin is present in an amount equal to or greater than about 95% by weight. Any purification method deemed suitable by one of skilled in the art can be used.
- the sample is further purified by distillation.
- the sample is further purified by flash distillation.
- distillation, including flash distillation is effective at removing the cold insolubles.
- the sample is further purified by liquid chromatography. In further embodiments, the sample is further purified by silica filtration, alumina filtration or clay filtration. In one embodiment, the crude farnesene composition is further purified by silica filtration and the resulting purified farnesene composition is greater than 97% pure by GCMS.
- the crude farnesene composition is fairly stable as judged by hydrogenation times which stay relatively constant over time.
- the hydrogenation times for the purified farnesene composition increases over time.
- the hydrogenation time of a recently purified farnesene composition (time 0) is similar to that of the chemically synthesized counterpart in which the ⁇ -tocopherol is removed.
- the purified farnesene samples were further analyzed. In certain embodiments, these samples comprised farnesene in an amount that is equal to or greater than about 93% by weight based on GCMS. In certain embodiments, farnesene is present in an amount that is equal to or greater than about 95% by weight or, in certain embodiments equal to or greater than about 97% by weight.
- These purified farnesene samples further comprised the following compounds which were all in an amount that is at least about 0.05% by weight by GCMS: zingiberene (also known as ginger oil) which can be present in an amount that is equal to or greater than about 0.1%, 0.2%, 0.3%, 0.4%, 0.5%, 0.6%, or 0.7%; bisabolene which can be present in an amount that is equal to or greater than about 0.1%, 0.2%, 0.3%, 0.4%, 0.5%, 0.6%, or 0.7%; 10,11-dihydro-10,11-epoxyfarnesene which can be present in an amount that is equal to or greater than about 0.1%, 0.2%, 0.3%, 0.4%, 0.5%, 0.6%, or 0.7%; and farnesol which can be present in an amount that is equal to or greater than about 0.1%, 0.25%, 0.5%, 0.75%, 1%, 1.5%, or 2%.
- zingiberene also known as ginger oil
- bisabolene which can be present in an amount that is equal to or
- the degradation in farnesene was correlated directly with peroxide concentrations which increased over time in the purified samples.
- Farnesene can be stabilized against peroxide formation by various antioxidants such as ⁇ -tocopherol.
- ⁇ -tocopherol some of the most commonly used antioxidants such as ⁇ -tocopherol have been found to inhibit hydrogenation.
- phenolic antioxidants were found to stabilize immiscible olefins without impeding any subsequent hydrogenation.
- Illustrative examples of phenolic antioxidants include polyphenols such as resveratrol; monophenols such as 3-tert-butyl-4-hydroxyanisole; 2-tert-butyl-4-hydroxyanisole; 2,4-dimethyl-6-tert-butylphenol; and 2,6-di-tert-butyl-4-methylphenol; and catechols such as 4-tert-butylcatechol.
- the addition of up to 3 weight % of a phenolic antioxidant were shown not to affect hydrogenation rates or times.
- the hydrogenation times of purified farnesene composition stabilized with 100 ppm of a phenolic antioxidant was comparable to that seen for the chemically synthesized counterpart in which the ⁇ -tocopherol is removed.
- phenolic antioxidants such as TBC did not further improve the hydrogenation rate of a crude olefin composition.
- the crude olefin composition appears to perform slightly better in the absence of a phenolic antioxidant than with it.
- hydrogenation methods for microbial-derived olefins are provided. Any known hydrogenation method can be used to hydrogenate microbial-derived olefins so long as the purified olefin composition comprises a phenolic antioxidant.
- a method provided herein comprises:
- the immiscible olefin is part of a crude olefin composition. In certain embodiments, the immiscible olefin is part of a purified olefin composition. In certain embodiments, the immiscible olefin is part of a stabilized purified olefin composition.
- the hydrogenation reaction occurs at a temperature equal to or greater than room temperature. In certain embodiments, the hydrogenation reaction occurs at a temperature equal to or greater than 20° C., 30° C., 40° C., 50° C., 60° C., 70° C., 80° C., 90° C., 100° C., 110° C., 120° C., 130° C., 140° C., 150° C., 160° C., 170° C., 180° C., 190° C., or 200° C. In certain embodiments, hydrogenation can occur at temperatures below 100° C. when hydrogenating an immiscible olefin.
- catalyst life is significantly extended if hydrogenation of an immiscible olefin is conducted above 100° C.
- the hydrogenation reaction occurs at a temperature equal to or greater than about 110° C., 120° C., 130° C., 140° C., 150° C., 160° C., 170° C., 180° C., 190° C., or 200° C.
- the hydrogenation reaction occurs at a temperature between about 110° C. and about 400° C.
- cracking side reactions become significant if the hydrogenation occurs at a temperature greater than about 400° C.
- the hydrogenation reaction occurs at a temperature between about 110° C. and about 350° C.
- the hydrogenation reaction occurs at a temperature between about 110° C. and about 300° C. In certain embodiments such as when hydroprocessing catalysts are used, the hydrogenation reaction occurs at a temperature between about 170° C. and about 350° C. In certain embodiments, the hydrogenation reaction occurs at a temperature between about 170° C. and about 240° C.
- FIG. 7 The benefits of performing the hydrogenation of microbial-derived olefins at temperature above 100° C. are shown in FIG. 7 .
- process LHSV Liquid Hourly Space Velocity
- Various compositions of 5% farnesene and 95% decane were hydrogenated at a pressure of 500 psig using 20% Ni/Al 2 O 3 catalyst diluted 4 ⁇ with glass beads.
- the farnesene in the farnesene composition is a purified microbial-derived farnesene and the hydrogenation reaction occurs at 100° C.
- the catalyst can deactivate rapidly over one day and continues to deactivate over three days.
- spent catalyst can be recovered by increasing temperature to greater than 100° C.
- the hydrogen uptake was recovered almost fully by increasing temperature to greater than 100° C. (in this case 150° C.).
- the third part of the plot demonstrates that chemically-derived farnesene can be hydrogenated at 100° C. with little or no catalyst deactivation.
- the hydrogenation reaction occurs in a slurry reactor. In certain embodiments, the hydrogenation reaction occurs in a fixed bed reactor. In certain embodiments, the hydrogenation reaction occurs in a fluidized bed reactor. In certain embodiments, the hydrogenation reaction occurs in a batch reactor. In further embodiments, the hydrogenation reaction occurs in a continuous flow reactor.
- Hydrogen for use in the process can be obtained from any source deemed suitable by one of skill in the art.
- exemplary sources include Linde Group, Air Products Praxair, and Air Liquid.
- hydrogen can be generated by steam methane reforming where pressurized natural gas and deionized water are fed to a steam methane reformer and converted to hydrogen via the following overall reaction: CH 4 (gas)+2H 2 O(gas) ⁇ CO 2 (gas)+4H 2 (gas).
- Carbon monoxide, carbon dioxide, water, and other gaseous contaminants can be separated from hydrogen via pressure-swing adsorption.
- the resulting hydrogen purity is typically 99% or greater.
- Another method for in situ hydrogen generation is by electrolysis. De-mineralized water is fed to an electrolysis unit and is converted to hydrogen via the following reaction: 2H 2 O(liquid) ⁇ O 2 (gas)+2H 2 (gas).
- the hydrogen composition used in the process is at least about 85%, 90%, 95%, 97%, 99% 99.5% or 99.99% pure.
- residual CO X is ⁇ 50 ppm.
- the hydrogen composition includes no measurable H 2 S.
- any hydrogenation catalyst can be used in the practice of a process provided herein.
- Exemplary catalysts are described, for example, in U.S. Pat. Nos. 6,403,844; 5,379,767; 5,151,172; 4,968,612; and 3,702,348.
- the catalyst is selected from Ni, Pd, Ru, Pt, Rh, Ir, Cu and Fe; alloys of the platinum group catalysts with promoters or stabilizers such as Mo, Co, Mg, and Zn; Raney-type porous catalysts, such as Ni/Al, Co/Al, and Cu/Al; and hydroprocessing catalysts, such as NiMoS and CoMoS.
- the catalyst can be provided in any suitable form, with a minimum dimension of, for example, at least 1 mm. Specific particle dimensions can be selected based upon reaction conditions and the type of catalyst bed being used.
- the catalyst can include any shape providing sufficient surface area, including but not limited to, cylinders, tablets, granules, spheres, lobed cylinders, or combinations thereof.
- the catalyst can also contain holes or passages.
- the particles can be formed by methods known in the art, such as, for example, extrusion or tabletting, or the like.
- a catalyst is selected by balancing reactivity with costs.
- the order of reactivity was found to be Pd>Rh>Pt>>Ru.
- FIG. 6 shows the hydrogenation rate of limonene at 0.5, 1, 2, and 3 equivalents of hydrogen at 100° C. and 50 mg of catalyst loading.
- Ni-based catalysts were identified as a very cost effective option while being capable of operating at extremely high LHSVs (Liquid Hourly Space Velocity).
- LHSVs Liquid Hourly Space Velocity
- a recent price for Ni which is typically priced by the pound was $0.33/oz.
- Exemplary Ni catalysts include “Raney Ni”, “sponge Ni”, and “skeletal Ni”.
- the catalyst is selected from Ni and Pd catalyst.
- any suitable material with high mechanical strength, high thermal stability, and low surface tension with supported metals can be used.
- useful support materials include, for example, silica, titania, zirconia, alumina, keiselguhr, magnesia, calcium aluminate cements, other inorganic carriers, carbon, and other known materials or modified versions of these supports such as base-treated versions, or versions with stabilizing additives such as MgO or oxides from the Lanthanide series.
- a catalyst support can be in the form of a pellet or extrudate with size dimensions on the order of 0.1-5 mm, 0.5-5 mm, 1-5 mm, 1-4, or 1-3 mm.
- Exemplary Ni catalysts with a fixed bed support include Al 2 O 3 supported Ni, Si-supported Ni, and sponge-type Ni. The activity of these catalysts can be optionally further modulated by the addition of a promoter or stabilizer such as Mo.
- Preferred Ni-based catalysts include Al 2 O 3 supported catalysts such as 20%, 12%, or 8% Ni/Al 2 O 3 . These Ni-based catalysts also have a price advantage: although both 20% Ni/Al 2 O 3 and 0.3% Pd/Al 2 O 3 catalysts can provide similar hydrogenation performance, the cost per unit reactor volume of the 20% Ni/Al 2 O 3 catalyst is approximately 40% of the cost of the 0.3% Pd/Al 2 O 3 catalyst.
- the catalyst for use in a process provided herein is selected from 20% Ni/Al 2 O 3 and 0.3% Pd/Al 2 O 3 .
- any suitable fixed bed reactor can be used.
- Exemplary reactors include a one-stage fixed bed reactor, a two-stage fixed bed reactor, and a multi-stage fixed bed reactor.
- exemplary configurations include: i) cocurrent gas-liquid downflow where reactant liquid and hydrogen gas is fed to a fixed bed reactor cocurrently to the top, described, for instance, by R. Gupta, in “Cocurrent Gas-Liquid Downflow in Packed Beds”, Chapter 19, of the Handbook of Fluids in Motion (1983); ii) cocurrent upflow where reactant liquid and hydrogen gas are fed to a fixed-bed reactor cocurrently to the bottom, and iii) countercurrent operations where reactant liquid and hydrogen gas are fed to a fixed-bed reactor countercurrently with liquid fed to the top trickling through rising hydrogen that is fed to the bottom, as described by P. Trambouze, in “Countercurrent Two-Phase Flow Fixed Bed Catalytic Reactions,” Chemical Engineering Science , Vol 45, No. 8, pp 2269-2275 (1990).
- the hydrogenation reactions described herein can be extremely exothermic, particularly when the immiscible olefin has multiple double bonds. As a consequence, strategies for removing potentially large amounts of heat need to be in place. For example, the hydrogenation of farnesene would result in a temperature rise of about 1000° C. if performed adiabatically. Thus, if hydrogenation were to occur in a slurry reactor or an ebullated bed reactor, heat would need to be continually removed. Because these systems are well-mixed, the heat of reaction can be transferred to internal cooling coils or external cooling jackets efficiently. Because of the complexities in having mechanical agitation, the limitation in size imposed thereof, as well as the requirement for catalyst filtration, mechanically-agitated slurry reactors may be more useful for smaller scale reactions.
- fixed bed reactors are used for large scale hydrogenations. These reactors have the advantage of simplicity because they require no mechanical agitation or catalyst filtration.
- a plurality of small diameter reaction tubes can be used.
- the small diameter can allow heat of reaction to be conducted radially out of the tubes effectively due to the short distance the heat needs to conduct over.
- a chilled product stream can be recycled from the reactor effluent to act as a diluent.
- the diluent is the intended product, a saturated immiscible olefin.
- the cold effluent can act as a heat sink for the heat of reaction so that the temperature rise for a fixed rate of reactant addition decreases as more product liquid is mixed into the feed.
- This strategy is particularly effective when the hydrogenation of the reactant exhibits zero order kinetics.
- FIG. 8 is a plot of the hydrogen uptake versus various dilution of farnesene. A calculated curve for a first order reaction based on hydrogen uptake of 20% farnescene concentration is shown along with the observed response for farnesene. As it can be seen, because a reactant like farnesene exhibits zero order kinetics, dilute solutions (less than ⁇ 20%, ⁇ 15%, ⁇ 10%, and even ⁇ 5%) can be efficiently hydrogenated.
- the diluent is a compound or composition that is inert under the employed hydrogenation conditions.
- Illustrative examples include saturated hydrocarbons that are not the hydrogenated immiscible olefin.
- diluents can be n-pentane, n-hexane, n-heptane, n-octane, n-decane, and the like.
- the diluent is a hydrogenated immiscible olefin. In certain embodiments, the diluent is a saturated immiscible olefin.
- a hydrogenation method using a fixed bed reactor comprises:
- a hydrogenation method comprises:
- the immiscible olefin is part of a crude olefin composition. In certain embodiments, the immiscible olefin is part of a purified olefin composition.
- the diluent composition comprises a hydrogenated immiscible olefin. In certain embodiments, the diluent composition comprises a saturated immiscible olefin. In certain embodiments, the diluent composition comprises recycled hydrogenated immiscible olefin in combination with one or more other diluents. In further embodiments, the diluent composition comprises recycled saturated immiscible olefin in combination with one or more other diluents.
- the feed stream comprises about 1%, 5%, 10%, 25%, 50%, 75%, 90%, 95%, 99% or less diluent based on total weight of the immiscible olefin. In certain embodiments, the feed stream comprises about 50 to 95%, 30 to 95%, 20 to 95%, or 5 to 99% diluent based on total weight of the immiscible olefin. In certain embodiments, the feed stream comprises about 99%, 95%, 90%, 85%, 75%, 65%, 55%, 45%, 35%, 25%, 15%, 5% or 1% diluent based on total weight of the immiscible olefin.
- the feed stream comprises about 1%, 5%, 10%, 25%, 50%, 75%, 90%, 95%, 99% or less hydrogenated immiscible olefin based on total weight of the diluent. In further embodiments, the feed stream comprises about 50 to 95%, 50 to 90%, 30 to 95%, 20 to 95%, 5 to 97% or 60 to 85% hydrogenated immiscible olefin based on total weight of the diluent. In certain embodiments, the feed stream comprises about 99%, 95%, 90%, 85%, 75%, 65%, 55%, 45%, 35%, 25%, 15%, 5% or 1% hydrogenated immiscible olefin based on total weight of the diluent.
- the feed stream comprises about 50 to 95%, 50 to 90%, 30 to 95%, 20 to 95%, 5 to 97% or 60 to 85% saturated immiscible olefin based on total weight of the diluent. In further embodiments, the feed stream comprises about 99%, 95%, 90%, 85%, 75%, 65%, 55%, 45%, 35%, 25%, 15%, 5% or 1% saturated immiscible olefin based on total weight of the diluent.
- the feed stream comprises about 5%, 10%, 25%, 50%, or 75% or less immiscible olefin based on total weight of the feed stream. In further embodiments, the feed stream comprises about 1 to 50%, 5 to 50%, 5 to 25%, 10 to 50%, 10 to 40% or 10 to 25% immiscible olefin based on total weight of the feed stream. In certain embodiments, the feed stream comprises about 50%, 40%, 30%, 25%, 20%, 10%, 5% or 1% immiscible olefin based on total weight of the feed stream.
- the catalyst is a Pd catalyst. In certain embodiments the catalyst is a Ni catalyst. In certain embodiments, the catalyst is Ni/Al 2 O 3 .
- the temperature difference between the inlet and the outlet of the fixed bed reactor is not more than 200° C. In certain embodiments, the temperature difference between the inlet and the outlet of the fixed bed reactor is not more than 100° C. In certain embodiments, the temperature difference between the inlet and the outlet of the fixed bed reactor is not more than 50° C.
- FIG. 9 is a schematic of an exemplary fixed bed hydrogenation system.
- the system comprises a primary reactor 3 (with primary catalyst 4 ).
- the system comprises a secondary reactor 6 (with secondary catalyst 7 ).
- the primary catalyst and the secondary catalyst may be identical or they may be different. If the system comprises only a primary reactor, this is a one-stage reactor where hydrogenation occurs in the primary reactor and the hydrogenated immiscible olefin is separated into two fractions: a recycling fraction and a product fraction.
- the recycling fraction is then recirculated as a diluent for the immiscible olefin feed.
- the hydrogenated immiscible olefin that is the product fraction can be used without further treatment.
- the system comprises both a primary and secondary reactor, this is a two-stage reactor.
- hydrogenation occurs in the primary reactor and the hydrogenated immiscible olefin is separated into two fractions: a recycling fraction and a product fraction.
- the recycling fraction is then recirculated as a diluent for the immiscible olefin feed to the primary reactor.
- the hydrogenated immiscible olefin that is the product fraction can be further hydrogenated to remove any residual unsaturation.
- the system can comprise a feed holding tank 1 , a liquid pump 2 , a separator drum 5 to separate gas from liquid, and hydrogen recycle compressor 21 .
- the system can include one or more of the following: a filter for immiscible olefin feed 8 , a startup heater to heat the feed 9 to a desired temperature, an interchanger 10 a and a cooler 10 b for the product exiting from the primary reactor, a cooler 11 for the product exiting from the secondary reactor, a cooler 12 for hydrogen exiting the separator drum, a tee or Venturi-type eductor 13 where the immiscible olefin feed is mixed with hydrogen, a primary reactor inlet 14 , a primary reactor outlet 15 , a knock-out pot 16 to separate gas and vapour, a secondary reactor inlet 17 , a secondary reactor outlet 18 , a vent 19 to purge gases from the system and a liquid pump 20 .
- immiscible olefin is mixed with a diluent.
- immiscible olefin feed entering the reactor comprises between about 5% and 20% immiscible olefin by volume. In certain embodiments, immiscible olefin feed entering the reactor is between about 5%, 10%, 15% and 20% immiscible olefin by volume.
- the diluted immiscible olefin feed is mixed with hydrogen in a tee or Venturi-type eductor 13 .
- about 1-1000%, 10-500 or 50-100% stoichiometric excess hydrogen, or about 100-5000, 100-2000, 200-1000 or 200-400 standard cubic feet per barrel of feed (scf/bbl) is used in the process.
- about 100% stoichiometric excess hydrogen, or about 200 standard cubic feed per barrel of feed (scf/bbl) is used in the process.
- the hydrogenation process is carried out at pressures between about 100 psig to about 700 psig.
- the pressure typically is between 100 and 700 psig at reaction inlet 14 and between 5 and 10000 psig at reaction outlet 15 .
- pressure at reaction inlet 14 is about 400 psig, 450 psig, 500 psig, 530 psig or 550 psig.
- pressure at reaction inlet 14 is about 530 psig.
- pressure at reaction outlet 15 is about 400 psig, 450 psig, 500 psig, or 550 psig.
- pressure at reaction inlet 14 is about 530 psig and pressure at outlet 15 is about 500 psig.
- the temperature during the process depends upon the operating pressures but typically a hydrogenation process is carried out at temperature greater than 100° C. In certain embodiments, the temperature is about 110 to 200° C. at the inlet 14 and between about 150 to 350° C. at the outlet 15 .
- an axial temperature rise is specified based on the difference between the reaction light-off temperature and the temperature at which the catalyst begins to foul.
- in the hydrogenation process is near, but above the temperature at which the hydrogenation of begins, i.e., light-off temperature, and below the temperature at which catalyst fouling or lost product yield are significant.
- the axial temperature rise in the process is in the range of 10 to 300° C.
- the axial temperature rise in the process is about 10, 20, 30, 40, 45, 50, 55, 60, 65, 70, 80, 100, 150, 200 or 300° C. Exemplary hydrogenation reactions with axial temperature rise at about 200° C. are described in U.S. Pat. No. 3,796,764.
- the temperature at the inlet 14 of the reactor is about 150° C., and the pressure is about 530 psig.
- the multi-phase feed flow and hydrogen stream are forced down the reactor 3 by the dynamic pressure drop, and exits the reactor at about 500 psig.
- primary reactor 3 comprises a sacrificial layer of catalyst or an adsorbent at the head of the reactor, to accumulate any irreversibly binding catalyst poisons and prevent them from accumulating on the catalyst below.
- the sacrificial layer is composed of a support having a larger particle size, larger pore dimensions, and/or lower metal loading than the catalyst.
- larger particle and pore dimensions of the sacrificial layer support allow more material to accumulate on the sacrificial section before the pores and interstitial spaces become clogged, which results in large pressure drop necessary to drive flow.
- a lower metal content of the sacrificial layer can reduce catalyst cost and can decrease hydrogenation rate at active sites, which can increase hydrogen availability at active sites and can decrease the potential for side reactions, including catalyst coking reactions that may occur in the absence of hydrogen.
- one, two, three or multiple sacrificial layers are present in the fixed bed.
- the sacrificial layer of catalyst comprises a topmost layer of a catalyst support material, such as Al 2 O 3 , followed by a layer of a low loading of Ni on a suitable support, such as Al 2 O 3 , in order to prolong the life of the sacrificial layers.
- Primary reactor 3 can further comprise a primary catalyst 4 .
- the primary catalyst is a Ni catalyst containing about 20% Ni supported on alumina extrudate, with an extrudate diameter of 1-5 mm.
- An example of a catalyst for use in the process is HTC NI 500 RP 1.2 mm available from Johnson-Matthey.
- the Ni loading in the catalyst is about 10%, 7%, 5%, 3% or less.
- the Ni loading in the catalyst is about 5% or less.
- the loading of Ni is about 60% or greater to minimize reactor volume and/or prolong catalyst life.
- the primary catalyst comprises 0.3% Pd/Al 2 O 3 .
- primary reactor 3 is sized with a reactor LHSV (Liquid Hourly Space Velocity) of 2, 5, 10, 15, 20 or 25, meaning that the ratio of the volumetric feed of liquid per hour to the volume of the primary catalyst bed is 2, 5, 10, 15, 20 or 25.
- the primary reactor is sized with a reactor LHSV of 20. If the immiscible olefin is diluted such that the feed is about 5% olefin and 95% hydrogenated product, this is equivalent to a process LHSV of 1, meaning that the ratio of the volumetric feed of immiscible olefin per hour to the volume of the primary catalyst bed is 1. In certain embodiments, the process is operated at LHSV of 2 or higher.
- the aspect ratio (ratio of reactor height:diameter) for reactor 3 is between about 0.5 to 100, 0.5 to 50, 0.5 to 30, 0.5 to 20, 1 to 15, 1 to 10, 1 to 7 or about 1 to 5. In certain embodiments, the aspect ratio is between 1 and 5. In general, lower aspect ratios decrease the pressure drop across the reactor, and therefore the electrical consumption of the recycle pump and recycle compressor. Higher aspect ratios can result in greater turbulent mixing of the reacting fluids, which improves mass and heat transfer, which may mitigate the potential for catalyst fouling and hot spot formation.
- the primary reactor contains a fluid distributor at the top of the reactor, for example, to evenly distribute the multi-phase reactant flow across the width of the reactor.
- one or more additional fluid distributors are positioned further into the reactor.
- one or more additional fluid distributors are positioned such that the fluid in the reactor is re-distributed once every 30 feet of catalyst height.
- product exiting at the bottom of the reactor is cooled by an interchanger 10 a and a cooler 10 b .
- the product exits at the bottom of the reactor at about 195° C. and about 500 psig.
- the excess hydrogen e.g., ⁇ 100 scf H 2 /bbl liquid
- Excess hydrogen can be pulled through a gas cooler 12 and a knock-out pot 16 by a recycle compressor 21 .
- a purge stream can release between ⁇ 1% and ⁇ 10% of the recycled hydrogen to vent 19 . This can allow small amounts of gases generated during the reaction, such as methane, to exit the system.
- the recycled hydrogen can be mixed with make-up hydrogen downstream of the compressor 21 , before mixing with the immiscible olefin feed.
- a fraction of the cooled liquid product from primary reactor 3 is recycled by a liquid pump 20 to the head of reactor 3 as a recycle product fraction to dilute incoming, fresh immiscible olefin feed.
- a remaining fraction of the liquid product can be diverted to a second reaction stage for polishing, which can reduce the residual unsaturation in the product fraction to the desired specification of the final hydrogenation product.
- a stoichiometric amount of hydrogen can be added to the second stage.
- the secondary reactor 6 contains a secondary catalyst 7 .
- the secondary catalyst has a similar catalyst loading as the primary catalyst 4 , or it may be loaded with a higher-activity catalyst, such as a high loading of supported Pd.
- the secondary reactor 6 comprises 5% Pd/Al 2 O 3 catalyst.
- the secondary reactor is sized with a reactor LHSV of 1, 2, 3, 4, 5 or 7. In certain embodiments, the secondary reactor is sized so that its LHSV is 5.
- the secondary reactor operates at about 300 to 500 psig. In certain embodiments, the secondary reactor operates at about 130-200° C. In certain embodiments, the secondary reactor operates at about 500 psig and at about 150-190° C.
- a hydrogenation method using existing hydroprocessing equipment is provided. Because hydroprocessing typically occurs in a refinery setting, they are able to handle high temperature reactions. In this method, hydrogenation of the immiscible olefin and hydroprocessing of the unfinished diesel occurs in the same reactor resulting in a saturated olefin and a finished diesel that has a reduced sulfur content that is 50 ppmw or less.
- the method comprises:
- the immiscible olefin is part of a crude olefin composition. In certain embodiments, the immiscible olefin is part of a purified olefin composition.
- the unfinished diesel has a sulfur content that is greater than 100 ppmw, greater than 500 ppmw, greater than 1000 ppmw, greater than 5000 ppmw, or greater than 10,000 ppmw.
- the unfinished diesel has a nitrogen content that is greater than 10 ppmw, greater than 50 ppmw, greater than 100 ppmw, greater than 500 ppmw, greater than 1000 ppmw, greater than 5000 ppmw, or greater than 10,000 ppmw.
- the effluent or the finished diesel has a sulfur content that is less than 30 ppmw. In other embodiments, the effluent has a sulfur content that is less than 15 ppmw. In still other embodiments, the effluent has a nitrogen content that is less than 1 ppmw.
- the unfinished diesel could be used as a diluent as described above.
- hydrogenation of the immiscible olefin and hydroprocessing of the unfinished diesel occurs in the same reactor but the effluent is recycled to control the temperature of the reaction.
- the method comprises:
- the immiscible olefin is part of a crude olefin composition. In certain embodiments, the immiscible olefin is part of a purified olefin composition.
- the unfinished diesel has a sulfur content that is greater than 100 ppmw, greater than 500 ppmw, greater than 1000 ppmw, greater than 5000 ppmw, or greater than 10,000 ppmw.
- the unfinished diesel has a nitrogen content that is greater than 10 ppmw, greater than 50 ppmw, greater than 100 ppmw, greater than 500 ppmw, greater than 1000 ppmw, greater than 5000 ppmw, or greater than 10,000 ppmw.
- the effluent has a sulfur content that is less than 30 ppmw. In other embodiments, the effluent has a sulfur content that is less than 15 ppmw. In still other embodiments, the effluent has a nitrogen content that is less than 1 ppmw.
- the feed stream comprises about 1%, 5%, 10%, 25%, 50%, 75%, 90%, 95%, 99% or less diluent based on total weight of the immiscible olefin. In certain embodiments, the feed stream comprises about 50 to 95%, 30 to 95%, 20 to 95%, or 5 to 99% diluent based on total weight of the immiscible olefin. In certain embodiments, the feed stream comprises about 99%, 95%, 90%, 85%, 75%, 65%, 55%, 45%, 35%, 25%, 15%, 5% or 1% diluent based on total weight of the immiscible olefin.
- the diluent composition comprises unfinished diesel that has a sulfur content that is greater than 50 ppmw and a hydrogenated immiscible olefin.
- the feed stream comprises about 1%, 5%, 10%, 25%, 50%, 75%, 90%, 95%, 99% or less unfinished diesel based on total weight of the diluent.
- the diluent composition comprises about 99%, 95%, 90%, 85%, 75%, 65%, 55%, 45%, 35%, 25%, 15%, 5% or 1% unfinished diesel based on total weight of the diluent.
- the feed stream comprises about 1%, 5%, 10%, 25%, 50%, 75%, 90%, 95%, 99% or less hydrogenated immiscible olefin based on total weight of the diluent. In further embodiments, the feed stream comprises about 50 to 95%, 50 to 90%, 30 to 95%, 20 to 95%, 5 to 97% or 60 to 85% hydrogenated immiscible olefin based on total weight of the diluent. In certain embodiments, the feed stream comprises about 99%, 95%, 90%, 85%, 75%, 65%, 55%, 45%, 35%, 25%, 15%, 5% or 1% hydrogenated immiscible olefin based on total weight of the diluent.
- the feed stream comprises about 50 to 95%, 50 to 90%, 30 to 95%, 20 to 95%, 5 to 97% or 60 to 85% saturated immiscible olefin based on total weight of the diluent. In further embodiments, the feed stream comprises about 99%, 95%, 90%, 85%, 75%, 65%, 55%, 45%, 35%, 25%, 15%, 5% or 1% saturated immiscible olefin based on total weight of the diluent.
- the feed stream comprises about 5%, 10%, 25%, 50%, or 75% or less immiscible olefin based on total weight of the feed stream. In further embodiments, the feed stream comprises about 1 to 50%, 5 to 50%, 5 to 25%, 10 to 50%, 10 to 40% or 10 to 25% immiscible olefin based on total weight of the feed stream. In certain embodiments, the feed stream comprises about 50%, 40%, 30%, 25%, 20%, 10%, 5% or 1% immiscible olefin based on total weight of the feed stream.
- the catalyst is a hydroprocessing catalyst. In certain embodiments the catalyst is a Ni catalyst. In certain embodiments, the catalyst is NiMo catalyst.
- a purified farnesene composition comprises:
- a microbial-derived mixture comprising farnesene in an amount that is equal to or greater than about 93% by weight and the following compounds each of which is present in an amount that is equal to or greater than about 0.1% by weight: bisabolene, zingiberene, farnesol, and farnesene epoxide; and,
- a phenolic antioxidant wherein the phenolic antioxidant is present an amount that is at least about 0.0001% by weight.
- a purified farnesene composition comprises:
- a microbial-derived mixture comprising farnesene in an amount that is equal to or greater than about 93% by weight and the following compounds each of which is present in an amount that is equal to or greater than about 0.1% by weight: bisabolene, zingiberene, farnesol, and farnesene epoxide; and,
- a phenolic antioxidant wherein the phenolic antioxidant is present an amount that is at least about 0.001% by weight.
- the phenolic antioxidant is present in an amount that is at least about 0.0005% by weight. In certain embodiments, the phenolic antioxidant is present in an amount that is at least about 0.005% by weight. In certain embodiments, the phenolic antioxidant is present in an amount that is between about 0.005% and about 0.5% by weight. In further embodiments, the phenolic antioxidant is present in an amount that is at least about 0.01% by weight. In additional embodiments, the phenolic antioxidant is present in an amount that is between about 0.05% and about 0.3% by weight. In certain embodiments, the phenolic antioxidant is present in an amount that is greater than about 0.5% by weight.
- the microbial-derived mixture further comprises squalene.
- the amount of squalene is generally less than about 0.5% based on total weight of the microbial-derived farnesene. In certain embodiments, the amount of squalene is about 0.05% to 0.5% based on total weight of the microbial-derived farnesene. In further embodiments, the amount of squalene is about 0.05%, 0.08%, 0.09%, or 0.1% based on total weight of the microbial-derived farnesene.
- the microbial-derived mixture further comprises farnesene dimers, such 1,4 and 1,3 adducts of farnesene.
- the amount of dimers is typically less than about 0.5% based on total weight of the microbial-derived farnesane. In certain embodiments, the amount of farnesene dimers is about 0.05%, 0.07%, 0.09%, 0.1%, 0.15%, 0.2%, 0.25%, 0.3% or 0.5% based on total weight of the microbial-derived farnesene. In certain embodiments, the amount of farnesene dimers is about 0.2% based on total weight of the microbial-derived farnesene.
- farnesene When the microbial-derived farnesene composition is hydrogenated, farnesene hydrogenates to farnesane. Both bisabolene and zingiberene hydrogenate to bisabolane. Farnesol becomes either farnesane (eliminates the hydroxyl group to form farnesene which then subsequently hydrogenates to become farnesane) or forms 2,6,10-trimethylundecane (plus methane and water). The latter reaction is depicted below: C 15 H 25 OH+5H 2 ⁇ C 14 H 30 +CH 4 +H 2 O
- Farnesene epoxide is hydrogenated to farnesol which is converted into farnesane or 2,6,10-trimethylundecane as depicted above.
- a purified farnesane composition comprises: farnesane in an amount that is equal to or greater than about 93% by weight and bisabolane in an amount that is equal to or greater than about 0.1% by weight, wherein the wt. % is based on the total weight of farnesane.
- the amount of bisabolane is equal to or greater than about 0.2%, 0.3%, 0.4%, 0.5%, 0.6%, 0.7%, 0.8%, 0.9% or 1.0% based on the total weight of farnesane.
- the composition comprises: farnesane in an amount that is equal to or greater than about 93% by weight; bisabolane in an amount that is equal to or greater than about 0.1% by weight; and 2,6,10-trimethylundecane in an amount that is equal to or greater than about 0.1% by weight.
- the purified composition will further comprise squalane.
- the amount of squalane is generally less than about 0.5% based on total weight of the farnesane. In certain embodiments, the amount of squalane is about 0.05% to 0.5% based on total weight of the farnesane. In further embodiments, the amount of squalane is about 0.05%, 0.08%, 0.09%, or 0.1% based on total weight of the farnesane.
- the purified farnesane composition further comprises farnesane dimers, the hydrogenated versions of farnesene dimers.
- the amount of dimers is typically less than about 0.5% based on total weight of the farnesane. In one embodiment, the amount of farnesene dimers is about 0.05%, 0.07%, 0.09%, 0.1%, 0.15%, 0.2%, 0.25%, 0.3% or 0.5% based on total weight of the farnesane. In one embodiment, the amount of farnesane dimers is about 0.2% based on total weight of the farnesane.
- the product of hydrogenation of a microbial-derived farnesene mixture comprises unsaturated farnesane.
- the product comprises a monounsaturated farnesane.
- the product comprises farnesane and an unsaturated farnesane.
- the product comprises about 0.1 to 50%, 0.1 to 25%, or 0.1 to 10% monounsaturated farnesane by total weight of the product.
- the product comprises about 0.1% monounsaturated farnesane.
- the product comprises about 10 to 99.9%, 20 to 99.9%, 50 to 99.9%, 50 to 99%, or 50 to 90% farnesane by total weight of the product.
- the product comprises at least about 99.9% farnesane by total weight of the product.
- a process provided herein comprises selective hydrogenation of farnesene to reduce one, two, three or four double bonds in farnesene.
- a process yields a combination of hydrogenated farnesene products.
- a product obtained in the hydrogenation process comprises a combination of farnesane and one or more monounsaturated farnesane products.
- a product comprises a monounsaturated farnesane in an amount from about 0.1 to 50% by total weight of the product. In certain embodiments, the amount of monounsaturated farnesane in a product is about 0.1, 1, 10, 25 or 50% by total weight of the product.
- This example describes the purification of farnesene that was produced by farnesene producing yeast strain A.
- the yeast cells were separated from the fermentation broth using a continuous disk stack nozzle centrifuge (Alfa Laval DX 203 B-34). In addition to removing the cells, this step also served to concentrate the bio-organic compound in a smaller volume. For this particular yeast strain, a twenty fold concentration resulted in a composition that was approximately half farnesene and half fermentation medium. So for a twenty fold concentration, approximately 95% of the volumetric flow exited the centrifuge from the nozzles (cells+liquid) as waste while approximately 5% of the volumetric flow was captured as concentrated bio-organic composition.
- the top layer comprised primarily the immiscible olefin.
- the middle layer comprised emulsion formed by the cells, the immiscible olefin and water.
- the bottom layer comprised the aqueous fermentation medium.
- the pH of the concentrated composition was adjusted to pH 8.3 using 5 N NaOH, followed by incubation at about 30° C. for approximately one hour.
- the concentrated composition (pH ⁇ 8.3) was then subjected to liquid/liquid separation using the same centrifuge.
- Table 1 details the amounts of the bio-organic compound in each of the three phases (bio-organic compound layer; emulsion; and the aqueous layer) of the basic concentrated bio-organic composition.
- the farnesene purity was 94.9% (w/w).
- the total acid number as measured by ASTM D 664 was 0.9 mg KOH/g.
- This example describes further purification of farnesene from Example 1.
- the farnesene was incubated with 0.4% w/w calcium hydroxide (e.g., Acros Organics, >98% pure, Cat. No. 21918000) for 2.5 hours at ambient temperature. This results in precipitation of various impurities which can be removed by various methods including centrifugation and filtration to yield a farnesene composition in which the organic acids that were extracted during the purification are neutralized. If desired, this neutralized composition can be further purified, for example, by distillation. Table 2 describes the total acid number and glycerin content of the various compositions.
- calcium hydroxide e.g., Acros Organics, >98% pure, Cat. No. 21918000
- the calcium hydroxide treatment reduces the total acid number without significantly affecting the impurity profiles of the other components of the composition with the exception of increased calcium.
- the high levels of calcium can be fully removed by other purification methods such as flash distillation.
- This example describes purification of the crude olefin composition to a purified olefin composition using alumina. This purification method also serves to neutralize the organic acids that are present in the crude olefin composition.
- Alumina sorbent is regenerated prior to use by heating at 250° C. for at least two hours.
- the crude olefin composition is brought to room temperature and is mixed with granular alumina (e.g., Selexsorb CDX) at 10% w/v of the bio-organic compound and mixed overnight.
- the mixture is then filtered by 0.45 ⁇ m filter and treated with 0.01% phenolic antioxidant such as 4-tert-butylcatechol.
- the resulting purified farnesene composition has a total acid number of 0 mg KOH/g.
- This example describes the hydrogenation of limonene in a batch reactor.
- the concentration of aromatic p-cymene in the “saturated” product of limonene hydrogenation has been found to be a function of catalyst type, temperature, pressure, and reaction time or LHSV (for flow reactors). The results are shown in FIG. 10 .
- This example describes the hydrogenation of limonene in a fixed bed reactor using a palladium catalyst.
- Limonene (FloraChem, >98% limonene) was blended with p-menthane or p-menthane/p-cymene mixtures to dilute the feed to 5-50% limonene, and was fed to a fixed bed of 1 L of 0.3% Pd/Al 2 O 3 extrudate obtained from Johnson-Matthey, at flow rates of 21-82 g/min. This is approximately equivalent to a reactor LHSV of ⁇ 1.6-6.2 L liquid/L cat/h or process LHSV of ⁇ 0.06-0.9 L limonene/L cat/h. The liquid feed was fed at room temperature, and warmed as a result of heat of reaction.
- the liquid feed and hydrogen were blended and fed to the top of a tubular reactor, so that it was operated in concurrent downflow. Tempered water at 80° C. was added to the middle section of the reactor to maintain the maximum temperature in the reactor at 150° C. or less. The reactor pressure was maintained at 50-90 psig. The excess hydrogen in the reactor effluent was maintained at 3.6-6.5 slpm.
- Table 5 The product compositions are shown in Table 5.
- This example describes the hydrogenation of limonene in a fixed bed reactor using a nickel catalyst.
- Limonene (FloraChem, >98% limonene) was blended with p-menthane or p-menthane/p-cymene mixtures to dilute the feed and was fed to a fixed bed of 1 L of 20% Ni Al 2 O 3 extrudate obtained from Johnson-Matthey. Feed concentration of limonene was 13-50%, and feed flow rate was 30-104 g/min.
- the reactor LHSV was 2.3-7.8 L liquid/L cat/h, and the process LHSV was 0.3-2.0 L limonene/L cat/h. Tempered water was added to the center section of the reactor to maintain the maximum temperature at 150° C. or less.
- Reactor pressures of 50-310 psig were utilized, and hydrogen effluent flow rate was maintained at 2.5-6.5 slpm.
- the product composition is shown below as a function of operating conditions. The product composition was substantially different than what was observed for 0.3% Pd/Al 2 O 3 .
- measured p-cymene concentration was zero in almost all of the cases shown, demonstrating aromatic hydrogenation activity, since the recycled liquid feed diluent contained p-cymene at the beginning of the test series. No olefinic unsaturated species were observed in the tests shown.
- Mass balance tests were performed during hydrogenation while using 1 L of 20% Ni/Al 2 O 3 extrudate obtained from Johnson-Matthey, while feeding 60 g/min of 25% limonene/p-menthane. This corresponds to a reactor LHSV of 4.5 L liquid/L cat/h or a process LHSV of 1.1 L limonene/L cat/h. Reactor pressure was maintained at 45-55 psig, temperature was maintained at ⁇ 150° C., and excess hydrogen in the reactor effluent was maintained at 5.5-7.0 slpm. Mass of the feed liquid was recorded repeatedly before and after operation for several hours. Mass of liquid recovered from the reactor effluent during the same time period was recorded. A mass increase of 0.76% is expected for complete hydrogenation of 25% limonene/p-menthane. The results are shown in the Table 7.
- the overall observed mass increase was 2.0%. The difference between expected and observed mass increase was probably due primarily to error caused by temporal variations in liquid holdup within the reactor system. This observed mass increase indicates that there was no measurable loss of liquid feed mass to side reactions such as hydrocracking.
- This example describes the hydrogenation of farnesene on a pilot scale.
- Microbial-derived farnesene which had been distilled with a wiped-film distillation apparatus, and which was stabilized with 100 ppmw 4-tert-butylcatechol (“p-TBC”), was fed to a fixed bed reactor in cocurrent downflow with excess hydrogen.
- the fixed bed reactor contained 1 L of 20% Ni/Al 2 O 3 extrudate obtained from Johnson-Matthey.
- the liquid feed rate was 9.6 L/h, and the liquid composition was 10-15% farnesene in recycled farnesane.
- the reactor LHSV was 9.6 L liquid/L cat/h, and the process LHSV was 0.96 to 1.4 L farnesene/L cat/h.
- the reactor jacket was maintained at 150° C. by heat transfer fluid.
- the reactor was maintained at 500 psig.
- This example describes the hydroprocessing of 5% farnesene with an unfinished diesel fuel containing 1.1 wt. % sulfur.
- the unfinished diesel contained 1.2 wt. % (12,000 ppmw) S, 100 ppmw N, and approximately 31 wt. % aromatics.
- the 10%-90% boiling range was 210° C.-370° C. based on simulated distillation.
- a NiMoS catalyst (Albemarle) was activated by sulfiding with dimethyldisulfide.
- Hydrogen was fed with the liquid feed at an H 2 /oil ratio of 300 N m3H 2 /m3 liquid feed (1,500 scf H2/bbl liquid).
- the reactor temperature profile and gas effluent composition were monitored, and the sample of unfinished diesel was processed for 72 hours.
- the sample of unfinished diesel was desulfurized from 12,000 ppmw 5 to 13-20 ppmw S under these processing conditions, and was denitrogenated from 100 ppmw N to 0.3-0.4 ppmw N.
- the Br number of the feed decreased from 1.4 to ⁇ 0.5 in the process, and total aromatics content decreased from about 31 wt % to about 21 wt %.
- Aromatics reduction was substantial for di- and tri-aromatics, and negligible for mono-aromatics.
- the total hydrogen consumption was about 57 N m3H 2 /m3 liquid feed, or 350 scf H 2 /bbl liquid.
- the liquid feed stream was switched from unfinished diesel to a sample containing 5 wt. % farnesene (in unfinished diesel).
- Reactor temperature and pressure were maintained at 340° C. and 650 psig, and the hydrogen:oil ratio was held constant at 300 N m3H 2 /m3 liquid feed (1,500 scf H 2 /bbl liquid).
- the reactor was run for 120 hours under these conditions.
- the farnesene-containing sample was desulfurized from 1.2 wt % S down to 25-32 ppmw S during the course of the 120 hours test.
- the S content in the effluent appeared to be drifting upwards slowly during the test from 25 to 32 ppmw, and no effort was made to decrease the S content of the effluent by adjusting operating conditions.
- the Br number of the farnesene-containing sample prior to hydroprocessing was substantially higher than that of unfinished diesel alone due to the presence of 5% farnesene, and was measured as 9.9.
- the Br number of the farnesene-containing sample was decreased to ⁇ 0.5 during the hydroprocessing, and complete conversion of farnesene to saturated C15 was observed with serial GC ⁇ GC analysis.
- NiMoS catalyst was removed and examined for carbon deposits after both samples were hydroprocessed. Elemental analysis showed concentrations of 7.3 wt % C and 12.1 wt % S, typical values observed for NiMoS hydroprocessing catalysts. This result indicated that there was no substantial increase in carbon deposition onto the catalyst from hydroprocessing the farnesene-containing sample.
- This example describes the performance of hydrogenation catalyst PRICAT NI HTC500RP 1.2 mm.
- the reactor was charged with 25 cm3 PRICAT Ni HTC500RP 1.2 mm catalyst in 4 discrete beds separated by coarse SiC (0.5-1.1 mm) again the catalyst interparticle void was filled with fine grade SiC (0.1-0.3 mm, 0.6 gSiC ⁇ g cat ⁇ 1 ).
- the catalyst was activated under the following reduction conditions:
- Example 9 The discharged catalyst in Example 9 was characterized to see how the catalyst had been modified.
- the catalyst was discharged in three portions—top, middle, and bottom of the reactor.
- the top and middle samples were analyzed by TGA to determine the decomposition temperature of the carbon species. Results show no loss of nickel from the catalyst and no significant loss of nickel surface area. A small amount of sulfur has been observed on the top and middle samples at 0.06 and 0.1% respectively. For both samples, all of the weight loss was observed before 500° C., with the maximum weight loss at around 300° C. which is indicative of a long chain hydrocarbon. No carbon build was observed (e.g. no coking) on the discharged catalyst, however up to 4 wt % hydrocarbon was found which was attributed to long chain hydrocarbons and which were not removable by extraction.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Water Supply & Treatment (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
Description
or an isomer thereof. In certain embodiments, the α-farnesene comprises a substantially pure isomer of α-farnesene. In certain embodiments, the α-farnesene comprises a mixture of isomers, such as cis-trans isomers. In further embodiments, the amount of each of the isomers in the α-farnesene mixture is independently from about 0.1 wt. % to about 99.9 wt. %, from about 0.5 wt. % to about 99.5 wt. %, from about 1 wt. % to about 99 wt. %, from about 5 wt. % to about 95 wt. %, from about 10 wt. % to about 90 wt. %, from about 20 wt. % to about 80 wt. %, based on the total weight of the α-farnesene mixture.
or an isomer thereof. In certain embodiments, the β-farnesene comprises a substantially pure isomer of β-farnesene. In certain embodiments, the β-farnesene comprises a mixture of isomers, such as cis-trans isomers. In further embodiments, the amount of each of the isomers in the β-farnesene mixture is independently from about 0.1 wt. % to about 99.9 wt. %, from about 0.5 wt. % to about 99.5 wt. %, from about 1 wt. % to about 99 wt. %, from about 5 wt. % to about 95 wt. %, from about 10 wt. % to about 90 wt. %, from about 20 wt. % to about 80 wt. %, based on the total weight of the β-farnesene mixture.
or a stereoisomer thereof. In certain embodiments, the farnesane comprises a substantially pure stereoisomer of farnesane. In certain embodiments, the farnesane comprises a mixture of stereoisomers, such as enantiomers and diastereoisomers, of farnesane. In further embodiments, the amount of each of the stereoisomers in the farnesane mixture is independently from about 0.1 wt. % to about 99.9 wt. %, from about 0.5 wt. % to about 99.5 wt. %, from about 1 wt. % to about 99 wt. %, from about 5 wt. % to about 95 wt. %, from about 10 wt. % to about 90 wt. %, from about 20 wt. % to about 80 wt. %, based on the total weight of the farnesane mixture.
-
- a) separating immiscible olefin from a mixture comprising an aqueous solution, microbial cells and immiscible olefin thereby forming a crude olefin composition; and
- b) adding a phenolic antioxidant to the crude olefin composition to form a stabilized microbial-derived olefin composition.
-
- a) separating immiscible olefin from a mixture comprising an aqueous solution, microbial cells and immiscible olefin thereby forming a crude olefin composition;
- b) purifying the crude olefin composition thereby forming a purified olefin composition; and
- c) adding a phenolic antioxidant to the purified olefin composition to form a stabilized purified microbial-derived olefin composition.
CH4(gas)+2H2O(gas)→CO2(gas)+4H2(gas).
2H2O(liquid)→O2(gas)+2H2(gas).
-
- a) providing a feed stream to the inlet of a fixed bed reactor wherein the feed stream comprises an immiscible olefin and a diluent composition;
- b) contacting the feed stream with hydrogen in the presence of a hydrogenation catalyst at a temperature greater than room temperature thereby producing an effluent;
- c) separating the effluent which comprises a hydrogenated immiscible olefin into a product stream comprising a hydrogenated immiscible olefin and a recycle stream comprising a hydrogenated immiscible olefin;
- d) adding the recycle stream as part of the diluent composition to a stream comprising the immiscible olefin to form a feed stream comprising recycled hydrogenated immiscible olefin;
- e) providing the feed stream comprising recycled hydrogenated immiscible olefin to the inlet of the fixed bed reactor; and
- f) repeating steps b)-e) at least once.
-
- a) providing a feed stream to the inlet of a fixed bed reactor wherein the feed stream comprises an immiscible olefin and a diluent composition;
- b) contacting the feed stream with hydrogen in the presence of a hydrogenation catalyst at a temperature greater than about 100° C. thereby producing an effluent;
- c) separating the effluent which comprises a hydrogenated immiscible olefin into a product stream comprising a hydrogenated immiscible olefin and a recycle stream comprising a hydrogenated immiscible olefin;
- d) adding the recycle stream as part of the diluent composition to a stream comprising the immiscible olefin to form a feed stream comprising recycled hydrogenated immiscible olefin;
- e) providing the feed stream comprising recycled hydrogenated immiscible olefin to the inlet of the fixed bed reactor; and
- f) repeating steps b)-e) at least once.
-
- a) providing a feed stream to the inlet of a fixed bed reactor wherein the feed stream comprises an immiscible olefin and a diluent composition; and
- b) contacting the feed stream with hydrogen in the presence of a hydrogenation catalyst at a temperature greater than about 100° C. thereby producing an effluent,
wherein the diluent composition is an unfinished diesel that has a sulfur content greater than 50 ppmw and the effluent comprises saturated immiscible olefin and the effluent has a sulfur content that is less than 50 ppmw.
-
- a) providing a feed stream to the inlet of a fixed bed reactor wherein the feed stream comprises an immiscible olefin and a diluent composition wherein the diluent composition comprises unfinished diesel that has a sulfur content that is greater than 50 ppmw such that the feed stream has a sulfur content that is greater than 50 ppmw;
- b) contacting the feed stream with hydrogen in the presence of a hydrogenation catalyst at a temperature greater than about 100° C. thereby producing an effluent wherein the effluent comprises saturated immiscible olefin and the effluent has a sulfur content that is less than 50 ppmw;
- c) diverting part of the effluent stream into a recycle stream comprising a finished diesel that has a sulfur content that is less than 50 ppmw;
- d) adding the recycle stream as part of the diluent composition to a stream comprising the immiscible olefin to form a feed stream comprising immiscible olefin and the feed stream has a sulfur content that is greater than 50 ppmw;
- e) providing the feed stream to the inlet of the fixed bed reactor; and
- f) repeating steps b)-e) at least once.
C15H25OH+5H2→C14H30+CH4+H2O
TABLE 1 |
liquid/liquid recovery of the concentrated composition at pH 8.3 |
Layer | % of farnesene | |
bio-organic | 82% (1.15 L) | |
|
8 | |
Aqueous | ||
10% | ||
TABLE 2 |
TAN & Glycerin content |
Ca(OH)2 | |||
Analytical Test | Crude | treated | Distilled |
TAN (mg KOH/g of immiscible | 0.5 | 0 | 0 |
olefin) |
Sterols | 0.31 | 0.315 | none detected | |
Glycerin % w | Free Glycerin | none | none | none detected |
detected | detected | |||
Total Glycerin | 0.048 | 0.047 | 0.007 | |
Monoglyceride | 0.086 | 0.087 | 0.027 | |
Diglyceride | 0.017 | 0.014 | none detected | |
Triglyceride | 0.213 | 0.205 | none detected | |
TABLE 3 |
Hydrocarbon quantification |
Ca(OH)2 | ||||
Crude | treated | Distilled | ||
Hydrocarbon | (% area) | (% area) | (% area) | |
Farnesene | 98.46 | 98.47 | 98.56 | |
Zingiberene | 0.286 | 0.285 | 0.287 | |
Bisabolene | 0.198 | 0.198 | 0.197 | |
Farnesene Epoxide | 0.193 | 0.194 | 0.193 | |
|
0 | 0.1 | 0 | |
Farnesol Isomer | 0.414 | 0.42 | 0.414 | |
Farnesol | 0.357 | 0.354 | 0.351 | |
|
0 | 0 | 0 | |
|
0 | 0 | 0 | |
|
0 | 0 | 0 | |
TABLE 4 |
Trace Metals |
Ca(OH)2 | ||||
Crude | treated | Distilled | ||
Metal/Element | (ppm) | (ppm) | (ppm) | |
|
4 | 2 | 3 | |
Calcium | <1 | 134 | <1 | |
Chromium | <1 | <1 | 1 | |
|
3 | 4 | <1 | |
Sodium | <3 | <3 | <3 | |
Nickel | <1 | <1 | 1 | |
|
6 | 6 | <1 | |
|
1 | 1 | 1 | |
|
6 | 6 | 2 | |
|
1 | 1 | 1 | |
Antimony | <1 | <1 | 1 | |
Following metals are <1 ppm: Silver, aluminum, barium, copper, iron, molybdenum, tin, vanadium |
TABLE 5 |
limonene hydrogenation products |
Feed flow | |||||||||
Reactive feed | rate | Pressure | Dimethyl | ||||||
concentration | g/min | LHSV | psig | octane | p-menthane | p-menthene | p- | limonene | |
5% | 21 | 1.6 | 50 | |||||
10% | 21 | 1.6 | 50 | 0.7% | 89% | 0.3% | 9.2% | 0.3% |
15% | 21 | 1.6 | 50 | 0.8% | 84% | 1.2% | 13.2% | |
20% | 24 | 1.8 | 50 | 0.9% | 87% | 11.0% | ||
25% | 24 | 1.8 | 50 | 1.0% | 86% | 12.0% | ||
30% | 24 | 1.8 | 50 | 0.9% | 85% | 13.1% | ||
35% | 24 | 1.8 | 50 | 0.9% | 83% | 14.6% | ||
35% | 24 | 1.8 | 50 | 0.9% | 83% | 15.0% | ||
43% | 24 | 1.8 | 50 | 1.0% | 80% | 17.7% | ||
50% | 24 | 1.8 | 50 | 1.0% | 78% | 0.7% | 20.0% | |
25% | 24 | 1.8 | 50 | 1.0% | 86% | 12.0% | ||
25% | 41 | 3.1 | 50 | 0.9% | 81% | 0.2% | 17.0% | |
25% | 64 | 4.8 | 50 | 1.0% | 78% | 0.9% | 19.0% | |
25% | 82 | 6.2 | 50 | 0.9% | 74% | 2.9% | 21.0% | |
25% | 82 | 6.2 | 90 | 1.0% | 79% | 0.6% | 18.0% | |
TABLE 6 |
Limonene product compositions |
Feed flow | |||||||||
Reactive feed | rate | Pressure | Dimethyl | ||||||
concentration | g/min | LHSV | Psig | octane | p-menthane | p-menthene | p- | limonene | |
13% | 30 | 2.3 | 50 | 1.2% | 99% | |||
25% | 30 | 2.3 | 50 | 1.1% | 99% | |||
35% | 30 | 2.3 | 50 | 1.2% | 99% | |||
50% | 30 | 2.3 | 50 | 1.2% | 99% | |||
25% | 40 | 3.0 | 55 | 1.1% | 98% | |||
25% | 78 | 5.9 | 58 | 1.1% | 99% | |||
25% | 104 | 7.8 | 47 | 1.1% | 92.0% | 6.5% | ||
25% | 100 | 7.5 | 101 | 1.1% | 99% | |||
25% | 100 | 7.5 | 200 | 1.1% | 99% | |||
25% | 99 | 7.4 | 310 | 1.1% | 99% | |||
TABLE 7 | |||||
MB1 | MB2 | MB3 | MB4 | SUM | |
feed start | 11250 | 16300 | 9700 | 11960 | |
feed end | 2500 | 2110 | 2080 | 2500 | |
Processed | 8750 | 14190 | 7620 | 9460 | 40020 |
Recovered | 8870 | 14680 | 7610 | 9670 | 40830 |
|
120 | 490 | −10 | 210 | 810 |
overall mass increase | 2.02% | |
TABLE 8 |
Hydrogenation Conditions |
Liquid | ||||||||
feed | Feed | Process | Reactor | Hydrogen | ||||
flow | concentration | LHSV | LHSV | feed | Temperature (° C.) | Pressure (psig) | Sam- |
rate | (L farnesene/ | (L farnesene/ | (L liquid/ | | Bath | 1 | 6 | Up- | Down- | ple | ||||||
Time | (L/h) | L Liquid feed) | L cat/h) | L cat/h) | (sipm) | SP | (top) | 2 | 3 | 4 | 5 | (bot) | stream | stream | # | |
9:15 | 9.6 | 10% | 0.96 | 9.6 | 7 | 150 | 128 | 195 | 174 | 164 | 158 | 150 | 503 | 500 | 2 |
10:25 | 9.6 | 10% | 0.96 | 9.6 | 7 | 150 | 118 | 202 | 180 | 168 | 160 | 151 | 503 | 500 | 3 |
14:20 | 9.6 | 15% | 1.44 | 9.6 | 10 | 150 | 123 | 233 | 193 | 174 | 163 | 150 | 503 | 500 | 7 |
15:20 | 9.6 | 15% | 1.44 | 9.6 | 10 | 150 | 124 | 231 | 192 | 173 | 162 | 150 | 503 | 500 | 8 |
16:21 | 9.6 | 15% | 1.44 | 9.6 | 10 | 150 | 124 | 241 | 195 | 175 | 163 | 152 | 503 | 500 | 9 |
21:26 | 9.6 | 15% | 1.44 | 9.6 | 10 | 150 | 140 | 246 | 195 | 173 | 162 | 151 | 504 | 501 | 38 |
22:19 | 9.6 | 15% | 1.44 | 9.6 | 10 | 150 | 140 | 246 | 195 | 173 | 162 | 151 | 503 | 500 | 39 |
23:16 | 9.6 | 15% | 1.44 | 9.6 | 10 | 150 | 140 | 246 | 195 | 173 | 162 | 151 | 503 | 500 | 40 |
-
- 120° C. (60 min dwell)
- 120-230° C. (1.67° C.·min-1)
- 230° C. (60 min dwell)
- Cool to first reaction temperature.
TABLE 9 |
Bromine index of reactor exit samples from various |
hydrogenation runs. |
|
|
|
| Bromine Index | ||
100 | — | 2300 | 4200 | |
140 | — | 750 | 2400 | |
175 | <100 | 200 | 800 | |
220 | — | <100 | 170 | |
TABLE 10 |
Gas analysis in ppm |
Process Conditions |
Temp | LHSV | Reactor Exit - Gas Analysis (ppm) |
(° C.) | (hr−1) | Methane | Ethane | Propane | Butane | Pentane |
175 | 10 | 4607 | 28 | 52 | 32 | 10 |
99 | 20 | 84 | 4 | 10 | 18 | 10 |
141 | 20 | 368 | 7 | 8 | 15 | 10 |
175 | 20 | 1950 | 18 | 37 | 30 | 10 |
175 | 20 | 2087 | 18 | 35 | 29 | 10 |
175 | 20 | 2181 | 16 | 35 | 27 | 10 |
220 | 20 | 6194 | 85 | 121 | 53 | 11 |
100 | 40 | 61 | 4 | 9 | 17 | 10 |
140 | 40 | 249 | 6 | 7 | 13 | 8 |
175 | 40 | 1499 | 15 | 31 | 28 | 10 |
175 | 40 | 1597 | 13 | 27 | 23 | 9 |
220 | 40 | 4808 | 57 | 97 | 48 | 10 |
Claims (36)
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/753,413 US8519204B2 (en) | 2009-04-02 | 2010-04-02 | Stabilization methods for microbial-derived olefins |
US13/951,160 US20130310615A1 (en) | 2009-04-02 | 2013-07-25 | Stabilization And Hydrogenation Methods For Microbial-Derived Olefins |
US13/951,137 US9611189B2 (en) | 2009-04-02 | 2013-07-25 | Stabilization and hydrogenation methods for microbial-derived olefins |
US15/458,907 US10183901B2 (en) | 2009-04-02 | 2017-03-14 | Stabilization and hydrogenation methods for microbial-derived olefins |
US16/228,567 US10894754B2 (en) | 2009-04-02 | 2018-12-20 | Stabilization and hydrogenation methods for microbial-derived olefins |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16618509P | 2009-04-02 | 2009-04-02 | |
US24990009P | 2009-10-08 | 2009-10-08 | |
US12/753,413 US8519204B2 (en) | 2009-04-02 | 2010-04-02 | Stabilization methods for microbial-derived olefins |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/951,137 Division US9611189B2 (en) | 2009-04-02 | 2013-07-25 | Stabilization and hydrogenation methods for microbial-derived olefins |
US13/951,160 Division US20130310615A1 (en) | 2009-04-02 | 2013-07-25 | Stabilization And Hydrogenation Methods For Microbial-Derived Olefins |
Publications (2)
Publication Number | Publication Date |
---|---|
US20100267971A1 US20100267971A1 (en) | 2010-10-21 |
US8519204B2 true US8519204B2 (en) | 2013-08-27 |
Family
ID=42634931
Family Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/753,413 Active 2031-12-31 US8519204B2 (en) | 2009-04-02 | 2010-04-02 | Stabilization methods for microbial-derived olefins |
US13/951,137 Active 2031-11-29 US9611189B2 (en) | 2009-04-02 | 2013-07-25 | Stabilization and hydrogenation methods for microbial-derived olefins |
US13/951,160 Abandoned US20130310615A1 (en) | 2009-04-02 | 2013-07-25 | Stabilization And Hydrogenation Methods For Microbial-Derived Olefins |
US15/458,907 Active 2030-07-31 US10183901B2 (en) | 2009-04-02 | 2017-03-14 | Stabilization and hydrogenation methods for microbial-derived olefins |
US16/228,567 Active 2030-04-18 US10894754B2 (en) | 2009-04-02 | 2018-12-20 | Stabilization and hydrogenation methods for microbial-derived olefins |
Family Applications After (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/951,137 Active 2031-11-29 US9611189B2 (en) | 2009-04-02 | 2013-07-25 | Stabilization and hydrogenation methods for microbial-derived olefins |
US13/951,160 Abandoned US20130310615A1 (en) | 2009-04-02 | 2013-07-25 | Stabilization And Hydrogenation Methods For Microbial-Derived Olefins |
US15/458,907 Active 2030-07-31 US10183901B2 (en) | 2009-04-02 | 2017-03-14 | Stabilization and hydrogenation methods for microbial-derived olefins |
US16/228,567 Active 2030-04-18 US10894754B2 (en) | 2009-04-02 | 2018-12-20 | Stabilization and hydrogenation methods for microbial-derived olefins |
Country Status (11)
Country | Link |
---|---|
US (5) | US8519204B2 (en) |
EP (1) | EP2414311B1 (en) |
CN (1) | CN102448916B (en) |
AU (1) | AU2010232469B2 (en) |
BR (3) | BRPI1015250B1 (en) |
CA (2) | CA2757000C (en) |
DK (1) | DK2414311T3 (en) |
ES (1) | ES2638774T3 (en) |
MX (1) | MX312376B (en) |
PT (1) | PT2414311T (en) |
WO (1) | WO2010115097A2 (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130310617A1 (en) * | 2009-04-02 | 2013-11-21 | Amyris, Inc. | Stabilization And Hydrogenation Methods For Microbial-Derived Olefins |
WO2015168658A1 (en) | 2014-05-02 | 2015-11-05 | Amyris, Inc. | Solvent compositions based on dihydrofarnesene |
US10294439B2 (en) | 2011-04-13 | 2019-05-21 | Amyris, Inc. | Olefins and methods for making the same |
US10695273B2 (en) | 2015-10-02 | 2020-06-30 | Amyris, Inc. | Compositions containing bio-based farnesene or compounds derived therefrom and their use in consumer and industrial products |
US11053446B2 (en) * | 2017-05-19 | 2021-07-06 | Reliance Industries Limited | Process for reducing total acid number of heat transfer fluid |
US11060124B2 (en) | 2017-05-03 | 2021-07-13 | Firmenich Incorporated | Methods for making high intensity sweeteners |
US11357246B2 (en) | 2015-10-29 | 2022-06-14 | Firmenich Incorporated | High intensity sweeteners |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7592295B1 (en) * | 2008-10-10 | 2009-09-22 | Amyris Biotechnologies, Inc. | Farnesene dimers and/or farnesane dimers and compositions thereof |
WO2012064740A1 (en) * | 2010-11-08 | 2012-05-18 | The Regents Of The University Of California | Isoprenoid based alternative diesel fuel |
US8846587B2 (en) | 2011-03-24 | 2014-09-30 | Elevance Renewable Sciences, Inc. | Functionalized monomers and polymers |
US9315748B2 (en) | 2011-04-07 | 2016-04-19 | Elevance Renewable Sciences, Inc. | Cold flow additives |
US20130197276A1 (en) * | 2012-01-31 | 2013-08-01 | Wolfgang Spiegler | Alkoxylates of hydrogenated farnesols and use thereof |
US9012385B2 (en) | 2012-02-29 | 2015-04-21 | Elevance Renewable Sciences, Inc. | Terpene derived compounds |
US9157040B2 (en) * | 2012-04-16 | 2015-10-13 | The United States Of America As Represented By The Secretary Of The Navy | Renewable high density turbine and diesel fuels |
US20150057204A1 (en) | 2013-03-12 | 2015-02-26 | Elevance Renewable Sciences, Inc. | Maleanized Ester Derivatives |
US20140274832A1 (en) | 2013-03-12 | 2014-09-18 | Elevance Renewable Sciences, Inc. | Maleinized ester derivatives |
US20170305819A1 (en) * | 2014-10-20 | 2017-10-26 | Novvi Llc | Selective partial hydrogenation of beta-farnesene |
US20190076376A1 (en) | 2015-07-10 | 2019-03-14 | University Of Miami | Methods for treating mucopolysaccharidosis |
US9822046B1 (en) * | 2016-05-19 | 2017-11-21 | Chevron U.S.A. Inc. | Farnesane alkylation |
US11208607B2 (en) | 2016-11-09 | 2021-12-28 | Novvi Llc | Synthetic oligomer compositions and methods of manufacture |
EP3652280A4 (en) | 2017-07-14 | 2021-07-07 | Novvi LLC | Base oils and methods of making the same |
WO2019014540A1 (en) | 2017-07-14 | 2019-01-17 | Novvi Llc | Base oils and methods of making the same |
US11590485B2 (en) | 2021-01-13 | 2023-02-28 | Saudi Arabian Oil Company | Process for modifying a hydroprocessing catalyst |
US20230365478A1 (en) * | 2022-05-12 | 2023-11-16 | Lummus Technology Llc | Production of heavy isoparaffinic hydrocarbons |
Citations (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3702348A (en) | 1969-10-20 | 1972-11-07 | Huels Chemische Werke Ag | Process for the preparation of saturated monocyclic monoterpenes |
GB1297768A (en) | 1970-07-09 | 1972-11-29 | ||
US4968612A (en) | 1984-07-27 | 1990-11-06 | Celgene Corporation | Continuous fermentation process for aromatic hydrocarbon bioconversion |
US5151172A (en) | 1991-05-03 | 1992-09-29 | Amoco Corporation | Distillate hydrogenation |
US5379767A (en) | 1992-09-02 | 1995-01-10 | The Regents Of The University Of California | MRI RF coil using zero-pitch solenoidal winding |
US6403844B1 (en) | 1998-11-24 | 2002-06-11 | Board Of Trustees Of Michigan State University | Condensed phase catalytic hydrogenation of lactic acid to propylene glycol |
WO2006108698A1 (en) | 2005-04-15 | 2006-10-19 | Exxonmobil Chemical Patents Inc. | Branched olefin compositions |
WO2007139924A2 (en) | 2006-05-26 | 2007-12-06 | Amyris Biotechnologies, Inc. | Apparatus for making bio-organic compounds |
WO2007140339A2 (en) | 2006-05-26 | 2007-12-06 | Amyris Biotechnologies, Inc. | Production of isoprenoids |
WO2008045555A2 (en) | 2006-10-10 | 2008-04-17 | Amyris Biotechnologies, Inc. | Fuel compositions comprising farnesane and farnesane derivatives and method of making and using same |
WO2008113041A2 (en) | 2007-03-14 | 2008-09-18 | Ls9, Inc. | Process for producing low molecular weight hydrocarbons from renewable resources |
WO2008133658A2 (en) | 2006-11-21 | 2008-11-06 | Amyris Biotechnologies, Inc. | Jet fuel compositions and methods of making and using same |
WO2008140492A2 (en) | 2006-11-21 | 2008-11-20 | Amyris Biotechnologies, Inc. | Jet fuel compositions and methods of making and using same |
WO2008151149A2 (en) | 2007-06-01 | 2008-12-11 | Solazyme, Inc. | Production of oil in microorganisms |
WO2009014636A2 (en) | 2007-07-20 | 2009-01-29 | Amyris Biotechnologies, Inc. | Fuel compositions comprising tetramethylcyclohexane |
US20090031617A1 (en) * | 2007-07-26 | 2009-02-05 | Chevron U.S.A. Inc. | Paraffinic Biologically-Derived Distillate Fuels With Bio-Oxygenates For Improved Lubricity And Methods Of Making Same |
US20090084025A1 (en) * | 2007-09-27 | 2009-04-02 | Ls9,Inc. | Reduction of the toxic effect of impurities from raw materials by extractive fermentation |
US7854774B2 (en) * | 2006-05-26 | 2010-12-21 | Amyris Biotechnologies, Inc. | Fuel components, fuel compositions and methods of making and using same |
US20100330642A1 (en) * | 2009-06-22 | 2010-12-30 | Joule Unlimited, Inc. | Biosynthesis of 1-alkenes in engineered microorganisms |
US20110203168A1 (en) * | 2008-11-28 | 2011-08-25 | Solazyme, Inc. | Novel Triglyceride and Fuel Compositions |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3796764A (en) | 1972-06-27 | 1974-03-12 | Texaco Inc | Hydrogenation of benzene to cyclohexane |
US4251672A (en) * | 1978-08-25 | 1981-02-17 | Exxon Research & Engineering Co. | Process for hydrogenating organic compounds with coprecipitated copper-nickel-silica catalysts |
US5183556A (en) | 1991-03-13 | 1993-02-02 | Abb Lummus Crest Inc. | Production of diesel fuel by hydrogenation of a diesel feed |
EP1245591B1 (en) * | 2000-06-30 | 2006-11-22 | Asahi Kasei Kabushiki Kaisha | Method for hydrogenation of diene polymers and copolymers |
GB0221489D0 (en) * | 2002-09-17 | 2002-10-23 | Ici Plc | Selective hydrogenation process |
US7179311B2 (en) | 2003-01-31 | 2007-02-20 | Chevron U.S.A. Inc. | Stable olefinic, low sulfur diesel fuels |
WO2006133908A2 (en) * | 2005-06-13 | 2006-12-21 | Exxonmobil Chemical Patents Inc. | Oligomerisation of olefins |
FI121425B (en) * | 2006-06-14 | 2010-11-15 | Neste Oil Oyj | Process for the production of base oil |
US7947478B2 (en) * | 2006-06-29 | 2011-05-24 | The Regents Of The University Of California | Short chain volatile hydrocarbon production using genetically engineered microalgae, cyanobacteria or bacteria |
JP2011518564A (en) * | 2008-04-23 | 2011-06-30 | ダニスコ・ユーエス・インク | Isoprene synthase mutants for isoprene production by improved microorganisms |
US8080070B2 (en) * | 2008-04-29 | 2011-12-20 | Air Liquide Process & Construction, Inc. | Hydrogenation of unsaturated hydrocarbons for syngas production |
US8173213B2 (en) * | 2008-05-28 | 2012-05-08 | Air Products And Chemicals, Inc. | Process stability of NBDE using substituted phenol stabilizers |
US7589243B1 (en) * | 2008-09-17 | 2009-09-15 | Amyris Biotechnologies, Inc. | Jet fuel compositions |
CN102448916B (en) | 2009-04-02 | 2015-04-29 | 阿迈瑞斯公司 | Stabilization and hydrogenation methods for microbial-derived olefins |
-
2010
- 2010-04-02 CN CN201080024164.8A patent/CN102448916B/en active Active
- 2010-04-02 MX MX2011010140A patent/MX312376B/en active IP Right Grant
- 2010-04-02 US US12/753,413 patent/US8519204B2/en active Active
- 2010-04-02 AU AU2010232469A patent/AU2010232469B2/en active Active
- 2010-04-02 CA CA2757000A patent/CA2757000C/en active Active
- 2010-04-02 DK DK10712281.4T patent/DK2414311T3/en active
- 2010-04-02 CA CA2989631A patent/CA2989631C/en active Active
- 2010-04-02 ES ES10712281.4T patent/ES2638774T3/en active Active
- 2010-04-02 PT PT107122814T patent/PT2414311T/en unknown
- 2010-04-02 WO PCT/US2010/029774 patent/WO2010115097A2/en active Application Filing
- 2010-04-02 BR BRPI1015250-4A patent/BRPI1015250B1/en active IP Right Grant
- 2010-04-02 EP EP10712281.4A patent/EP2414311B1/en active Active
- 2010-04-02 BR BR122018010313-2A patent/BR122018010313B1/en active IP Right Grant
- 2010-04-02 BR BR122018010309-4A patent/BR122018010309B1/en active IP Right Grant
-
2013
- 2013-07-25 US US13/951,137 patent/US9611189B2/en active Active
- 2013-07-25 US US13/951,160 patent/US20130310615A1/en not_active Abandoned
-
2017
- 2017-03-14 US US15/458,907 patent/US10183901B2/en active Active
-
2018
- 2018-12-20 US US16/228,567 patent/US10894754B2/en active Active
Patent Citations (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3702348A (en) | 1969-10-20 | 1972-11-07 | Huels Chemische Werke Ag | Process for the preparation of saturated monocyclic monoterpenes |
GB1297768A (en) | 1970-07-09 | 1972-11-29 | ||
US4968612A (en) | 1984-07-27 | 1990-11-06 | Celgene Corporation | Continuous fermentation process for aromatic hydrocarbon bioconversion |
US5151172A (en) | 1991-05-03 | 1992-09-29 | Amoco Corporation | Distillate hydrogenation |
US5379767A (en) | 1992-09-02 | 1995-01-10 | The Regents Of The University Of California | MRI RF coil using zero-pitch solenoidal winding |
US6403844B1 (en) | 1998-11-24 | 2002-06-11 | Board Of Trustees Of Michigan State University | Condensed phase catalytic hydrogenation of lactic acid to propylene glycol |
WO2006108698A1 (en) | 2005-04-15 | 2006-10-19 | Exxonmobil Chemical Patents Inc. | Branched olefin compositions |
US20080274523A1 (en) | 2006-05-26 | 2008-11-06 | Neil Stephen Renninger | Production of isoprenoids |
WO2007139924A2 (en) | 2006-05-26 | 2007-12-06 | Amyris Biotechnologies, Inc. | Apparatus for making bio-organic compounds |
US7854774B2 (en) * | 2006-05-26 | 2010-12-21 | Amyris Biotechnologies, Inc. | Fuel components, fuel compositions and methods of making and using same |
WO2007140339A2 (en) | 2006-05-26 | 2007-12-06 | Amyris Biotechnologies, Inc. | Production of isoprenoids |
US7846222B2 (en) * | 2006-10-10 | 2010-12-07 | Amyris Biotechnologies, Inc. | Fuel compositions comprising farnesane and farnesane derivatives and method of making and using same |
US7399323B2 (en) | 2006-10-10 | 2008-07-15 | Amyris Biotechnologies, Inc. | Fuel compositions comprising farnesane and farnesane derivatives and method of making and using same |
WO2008045555A2 (en) | 2006-10-10 | 2008-04-17 | Amyris Biotechnologies, Inc. | Fuel compositions comprising farnesane and farnesane derivatives and method of making and using same |
WO2008133658A2 (en) | 2006-11-21 | 2008-11-06 | Amyris Biotechnologies, Inc. | Jet fuel compositions and methods of making and using same |
WO2008140492A2 (en) | 2006-11-21 | 2008-11-20 | Amyris Biotechnologies, Inc. | Jet fuel compositions and methods of making and using same |
WO2008113041A2 (en) | 2007-03-14 | 2008-09-18 | Ls9, Inc. | Process for producing low molecular weight hydrocarbons from renewable resources |
WO2008151149A2 (en) | 2007-06-01 | 2008-12-11 | Solazyme, Inc. | Production of oil in microorganisms |
US20090047721A1 (en) | 2007-06-01 | 2009-02-19 | Solazyme, Inc. | Renewable Diesel and Jet Fuel from Microbial Sources |
WO2009014636A2 (en) | 2007-07-20 | 2009-01-29 | Amyris Biotechnologies, Inc. | Fuel compositions comprising tetramethylcyclohexane |
US20090031617A1 (en) * | 2007-07-26 | 2009-02-05 | Chevron U.S.A. Inc. | Paraffinic Biologically-Derived Distillate Fuels With Bio-Oxygenates For Improved Lubricity And Methods Of Making Same |
US20090084025A1 (en) * | 2007-09-27 | 2009-04-02 | Ls9,Inc. | Reduction of the toxic effect of impurities from raw materials by extractive fermentation |
US20110203168A1 (en) * | 2008-11-28 | 2011-08-25 | Solazyme, Inc. | Novel Triglyceride and Fuel Compositions |
US20100330642A1 (en) * | 2009-06-22 | 2010-12-30 | Joule Unlimited, Inc. | Biosynthesis of 1-alkenes in engineered microorganisms |
Non-Patent Citations (1)
Title |
---|
Pichika Ramaiah et al., The Journal of Organic Chemistry, 1995, vol. 60, No. 19, pp. 6211-6213. |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10183901B2 (en) * | 2009-04-02 | 2019-01-22 | Amyris, Inc. | Stabilization and hydrogenation methods for microbial-derived olefins |
US20130310615A1 (en) * | 2009-04-02 | 2013-11-21 | Amyris, Inc. | Stabilization And Hydrogenation Methods For Microbial-Derived Olefins |
US10894754B2 (en) | 2009-04-02 | 2021-01-19 | Amyris, Inc. | Stabilization and hydrogenation methods for microbial-derived olefins |
US9611189B2 (en) * | 2009-04-02 | 2017-04-04 | Amyris, Inc. | Stabilization and hydrogenation methods for microbial-derived olefins |
US20130310617A1 (en) * | 2009-04-02 | 2013-11-21 | Amyris, Inc. | Stabilization And Hydrogenation Methods For Microbial-Derived Olefins |
US10294439B2 (en) | 2011-04-13 | 2019-05-21 | Amyris, Inc. | Olefins and methods for making the same |
US11193078B2 (en) | 2011-04-13 | 2021-12-07 | Amyris, Inc. | Olefins and methods for making the same |
US11802100B2 (en) | 2011-04-13 | 2023-10-31 | Amyris, Inc. | Olefins and methods for making the same |
US10071034B2 (en) | 2014-05-02 | 2018-09-11 | Amyris, Inc. | Solvent compositions |
WO2015168658A1 (en) | 2014-05-02 | 2015-11-05 | Amyris, Inc. | Solvent compositions based on dihydrofarnesene |
US10695273B2 (en) | 2015-10-02 | 2020-06-30 | Amyris, Inc. | Compositions containing bio-based farnesene or compounds derived therefrom and their use in consumer and industrial products |
US11357246B2 (en) | 2015-10-29 | 2022-06-14 | Firmenich Incorporated | High intensity sweeteners |
US11758933B2 (en) | 2015-10-29 | 2023-09-19 | Firmenich Incorporated | High intensity sweeteners |
US11060124B2 (en) | 2017-05-03 | 2021-07-13 | Firmenich Incorporated | Methods for making high intensity sweeteners |
US11053446B2 (en) * | 2017-05-19 | 2021-07-06 | Reliance Industries Limited | Process for reducing total acid number of heat transfer fluid |
Also Published As
Publication number | Publication date |
---|---|
WO2010115097A2 (en) | 2010-10-07 |
US20130310617A1 (en) | 2013-11-21 |
BR122018010313B1 (en) | 2019-04-24 |
CA2757000C (en) | 2018-02-13 |
CA2989631C (en) | 2020-07-21 |
US10183901B2 (en) | 2019-01-22 |
US20190119184A1 (en) | 2019-04-25 |
US20100267971A1 (en) | 2010-10-21 |
US20170283346A1 (en) | 2017-10-05 |
PT2414311T (en) | 2017-09-08 |
MX312376B (en) | 2013-08-15 |
MX2011010140A (en) | 2011-11-29 |
CN102448916B (en) | 2015-04-29 |
US10894754B2 (en) | 2021-01-19 |
US9611189B2 (en) | 2017-04-04 |
AU2010232469A1 (en) | 2011-10-27 |
CA2757000A1 (en) | 2010-10-07 |
BRPI1015250A2 (en) | 2016-12-06 |
CN102448916A (en) | 2012-05-09 |
EP2414311A2 (en) | 2012-02-08 |
ES2638774T3 (en) | 2017-10-24 |
EP2414311B1 (en) | 2017-06-07 |
AU2010232469B2 (en) | 2013-09-19 |
DK2414311T3 (en) | 2017-09-18 |
CA2989631A1 (en) | 2010-10-07 |
BRPI1015250B1 (en) | 2019-04-24 |
WO2010115097A3 (en) | 2011-09-29 |
BR122018010309B1 (en) | 2020-11-10 |
US20130310615A1 (en) | 2013-11-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10894754B2 (en) | Stabilization and hydrogenation methods for microbial-derived olefins | |
KR100937081B1 (en) | Double bond hydroisomerization process | |
CN101027269A (en) | Process for the selective hydrogenation of alkynes and/or dienes in an olefin-containing hydrocarbon stream | |
KR20080007369A (en) | Improved double bond hydroisomerization process | |
US20170305819A1 (en) | Selective partial hydrogenation of beta-farnesene | |
FR2553760A1 (en) | PROCESS FOR SELECTIVE HYDROGENATION IN THE PRESENCE OF SOLVENT OF ACETYLENE COMPOUNDS OF A C4 HYDROCARBON CUT RICH IN BUTADIENE | |
US9896394B2 (en) | Method for improving propane dehydrogenation process | |
AU2009272608A1 (en) | Process for the hydrogenation of benzene | |
US9533924B2 (en) | Method for producing hydrocarbon material | |
WO2018044591A1 (en) | Production of neopentane | |
EP2017245A1 (en) | Process for production of dicyclopentadiene | |
CN1872819A (en) | Counter flow typed selective method for adding hydrogen | |
KR20190108593A (en) | Isomerization Process Using Feedstock Containing Dissolved Hydrogen | |
US3108142A (en) | Catalytic hydrogenation of carbocyclic compounds having olefinic double linkages | |
WO2020223166A1 (en) | Process for hydrogenation of 1,3-butadiene | |
CN111099950B (en) | Method for improving conversion rate of carbon five fraction hydrogenation reaction based on molybdenum-nickel/aluminum oxide catalysis | |
US20240034699A1 (en) | Flexible Benzene Production Via Selective-Higher-Olefin Oligomerization of Ethylene | |
EP3847144A1 (en) | Method for the production of mtbe and 1-butene from a c4 feed stream |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: AMYRIS BIOTECHNOLOGIES, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:OHLER, NICHOLAS L.;VASQUEZ, ROBERTO;REEL/FRAME:026142/0698 Effective date: 20100524 |
|
AS | Assignment |
Owner name: AMYRIS, INC., CALIFORNIA Free format text: CHANGE OF NAME;ASSIGNOR:AMYRIS BIOTECHNOLOGIES, INC.;REEL/FRAME:026994/0854 Effective date: 20100621 |
|
AS | Assignment |
Owner name: TOTAL GAS & POWER USA, SAS, FRANCE Free format text: SECURITY AGREEMENT;ASSIGNOR:AMYRIS, INC.;REEL/FRAME:030378/0447 Effective date: 20130426 |
|
AS | Assignment |
Owner name: AMYRIS BIOTECHNOLOGIES, INC., CALIFORNIA Free format text: CORRECTED COVER SHEET;ASSIGNORS:OHLER, NICHOLAS L.;VAZQUEZ, ROBERTO;REEL/FRAME:030889/0855 Effective date: 20100524 |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
AS | Assignment |
Owner name: MAXWELL (MAURITIUS) PTE LTD, SINGAPORE Free format text: SECURITY AGREEMENT;ASSIGNOR:AMYRIS, INC.;REEL/FRAME:031478/0933 Effective date: 20131016 |
|
AS | Assignment |
Owner name: TOTAL ENERGIES NOUVELLES ACTIVITES USA, FRANCE Free format text: SECURITY AGREEMENT;ASSIGNOR:AMYRIS, INC.;REEL/FRAME:031607/0314 Effective date: 20131016 |
|
AS | Assignment |
Owner name: AMYRIS, INC., CALIFORNIA Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:TOTAL ENERGIES NOUVELLES ACTIVITIES USA, SAS (F/K/A TOTAL GAS & POWER USA, SAS);REEL/FRAME:032551/0828 Effective date: 20131202 |
|
AS | Assignment |
Owner name: AMYRIS, INC., CALIFORNIA Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:TOTAL ENERGIES NOUVELLES ACTIVITES USA, SAS (F/K/A TOTAL GAS & POWER USA, SAS);REEL/FRAME:032554/0001 Effective date: 20131203 |
|
AS | Assignment |
Owner name: AMYRIS, INC., CALIFORNIA Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:MAXWELL (MAURITIUS) PTE LTD;REEL/FRAME:032578/0357 Effective date: 20131202 |
|
AS | Assignment |
Owner name: HERCULES TECHNOLOGY GROWTH CAPITAL, INC., CALIFORNIA Free format text: SECURITY INTEREST;ASSIGNOR:AMYRIS, INC.;REEL/FRAME:038878/0381 Effective date: 20140329 Owner name: HERCULES TECHNOLOGY GROWTH CAPITAL, INC., CALIFORN Free format text: SECURITY INTEREST;ASSIGNOR:AMYRIS, INC.;REEL/FRAME:038878/0381 Effective date: 20140329 |
|
AS | Assignment |
Owner name: STEGODON CORPORATION, MASSACHUSETTS Free format text: SECURITY INTEREST;ASSIGNOR:HERCULES CAPITAL INC.;REEL/FRAME:039048/0251 Effective date: 20160615 |
|
FPAY | Fee payment |
Year of fee payment: 4 |
|
AS | Assignment |
Owner name: NAXYRIS S.A., LUXEMBOURG Free format text: SECURITY INTEREST;ASSIGNOR:AMYRIS, INC.;REEL/FRAME:050081/0106 Effective date: 20190814 |
|
AS | Assignment |
Owner name: AMYRIS, INC., CALIFORNIA Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:STEGODON CORPORATION;REEL/FRAME:050206/0606 Effective date: 20180629 |
|
AS | Assignment |
Owner name: SCHOTTENFELD OPPORTUNITIES FUND II, L.P., NEW YORK Free format text: GRANT OF PATENT SECURITY INTEREST;ASSIGNOR:AMYRIS, INC.;REEL/FRAME:051072/0310 Effective date: 20191114 |
|
AS | Assignment |
Owner name: NAXYRIS S.A., LUXEMBOURG Free format text: SECURITY INTEREST;ASSIGNOR:AMYRIS, INC.;REEL/FRAME:051081/0729 Effective date: 20191112 |
|
MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 8TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1552); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY Year of fee payment: 8 |
|
AS | Assignment |
Owner name: FORIS VENTURES, LLC, CALIFORNIA Free format text: SECURITY INTEREST;ASSIGNOR:AMYRIS, INC.;REEL/FRAME:061703/0499 Effective date: 20220927 |
|
AS | Assignment |
Owner name: AMYRIS, INC., CALIFORNIA Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:SCHOTTENFELD OPPORTUNITIES FUND II, L.P.;REEL/FRAME:062760/0818 Effective date: 20210301 Owner name: AMYRIS, INC., CALIFORNIA Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:NAXYRIS S.A.;REEL/FRAME:062760/0753 Effective date: 20211228 |
|
AS | Assignment |
Owner name: MUIRISC, LLC, CALIFORNIA Free format text: SECURITY INTEREST;ASSIGNORS:AMYRIS CLEAN BEAUTY, INC.;AMYRIS FUELS, LLC;AB TECHNOLOGIES LLC;AND OTHERS;REEL/FRAME:064492/0518 Effective date: 20230802 |
|
AS | Assignment |
Owner name: EUAGORE, LLC, CALIFORNIA Free format text: SECURITY INTEREST;ASSIGNORS:AMYRIS, INC.;AMYRIS CLEAN BEAUTY, INC.;AMYRIS FUELS, LLC;AND OTHERS;REEL/FRAME:064619/0778 Effective date: 20230809 |
|
AS | Assignment |
Owner name: EUAGORE, LLC, CALIFORNIA Free format text: SECURITY INTEREST;ASSIGNOR:AMYRIS, INC.;REEL/FRAME:067528/0467 Effective date: 20240507 |